10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

    Commission File Number

    Exact Name of Registrant as Specified in its Charter, 
Principal Executive Office Address and Telephone Number

    State of Incorporation

    I.R.S. Employer Identification No.

     
001-33401

           Cinemark Holdings, Inc.
       3900 Dallas Parkway
       Plano, Texas 75093
       (972) 665-1000

Delaware

20-5490327

     
33-47040

           Cinemark USA, Inc.
       3900 Dallas Parkway
       Plano, Texas 75093
       (972) 665-1000

Texas

75-2206284

Securities registered pursuant to Section 12(b) of the Act:


	Title of Each Class	Trading Symbol(s)	Name of each exchange on which registered
Cinemark Holdings, Inc. ("Holdings")	Common stock, par value $.001 per share	CNK	New York Stock Exchange
Cinemark USA, Inc. ("CUSA")	None	None	None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Cinemark Holdings, Inc. Yes ☒ No ☐

Cinemark USA, Inc. Yes ☐ No ☒

(Note: As a voluntary filer, Cinemark USA, Inc. is not subject to the filing requirements of Section 13 or 15(d) of the Exchange Act. Cinemark USA, Inc. has filed all reports pursuant to Section 13 or 15(d) of the Exchange Act during the preceding 12 months as if it was subject to such filing requirements.)

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Cinemark Holdings, Inc. Yes ☒ No ☐

Cinemark USA, Inc. Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Cinemark Holdings, Inc.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

Cinemark USA, Inc.


Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Cinemark Holdings, Inc. Yes ☐ No ☒

Cinemark USA, Inc. Yes ☐ No ☒

As of July 26, 2024, 122,384,098 shares of common stock, $0.001 par value per share, of Cinemark Holdings, Inc. were issued and outstanding.

As of July 26, 2024, 1,500 shares of Class A common stock, $0.01 par value per share, and 182,648 shares of Class B common stock, no par value per share, of Cinemark USA, Inc. were outstanding and held by Cinemark Holdings, Inc.

Cinemark USA, Inc. meetS the conditions set forth in General Instructions (H)(1)(a) and (b) of Form 10-Q and IS therefore filing this form with reduced disclosure format pursuant to General Instructions (H)(2).

This combined Form 10-Q is separately filed by Holdings and CUSA. Information contained herein relating to any individual registrant is filed by such registrant on its own behalf. Each registrant makes no representation as to information relating to the other registrant. When this Form 10-Q is incorporated by reference into any filings with the SEC made by Holdings or CUSA, as a registrant, the portions of this Form 10-Q that relate to the other registrant are not incorporated by reference therein.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CINEMARK USA, INC. AND SUBSIDIARIES

TABLE OF CONTENTS


			Page
PART I. FINANCIAL INFORMATION

	Item 1.	Cinemark Holdings, Inc. and Subsidiaries Financial Statements (unaudited)
		Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023	3
		Condensed Consolidated Statements of Income for the three and six months ended June 30, 2024 and 2023	4
		Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2024 and 2023	5
		Condensed Consolidated Statements of Equity for the three and six months ended June 30, 2024 and 2023	6
		Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023	8
		Cinemark USA, Inc. and Subsidiaries Financial Statements (unaudited)
		Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023	9
		Condensed Consolidated Statements of Income for the three and six months ended June 30, 2024 and 2023	10
		Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2024 and 2023	11
		Condensed Consolidated Statements of Equity for the three and six months ended June 30, 2024 and 2023	12
		Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023	14
		Cinemark Holdings, Inc. and Cinemark USA, Inc. Notes to Condensed Consolidated Financial Statements	15

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	37

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	52

	Item 4.	Controls and Procedures	52

PART II. OTHER INFORMATION

	Item 1.	Legal Proceedings	54

	Item 1A.	Risk Factors	54

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	54

	Item 5.	Other Information	55

	Item 6.	Exhibits	60

SIGNATURES			61

Cautionary Statement Regarding Forward-Looking Statements

Certain matters within this Quarterly Report on Form 10-Q include “forward–looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. The “forward-looking statements” include our current expectations, assumptions, estimates and projections about the respective business and industry of Holdings and CUSA. They include statements relating to:

•

future revenue, expenses and profitability;

•

currency exchange rate and inflationary impacts;

•

the future development and expected growth of our business;

•

projected capital expenditures;

•

access to capital resources;

•

attendance at movies generally or in any of the markets in which we operate;

•

the number and diversity of popular movies released, the length of exclusive theatrical release windows and our ability to successfully license and exhibit popular films;

•

national and international growth in our industry;

•

competition from other exhibitors, alternative forms of entertainment and content delivery via streaming and other formats;

•

determinations in lawsuits in which we are a party; and

•

the ongoing recovery of our business and the motion picture exhibition industry from the effects of the COVID-19 pandemic and the 2023 writers’ and actors’ guilds strikes.

You can identify forward-looking statements by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. These statements are neither historical facts nor guarantees of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and are, therefore, subject to risks, inherent uncertainties and other factors, some of which are beyond our control and difficult to predict. Such risks and uncertainties could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a description of our risk factors, please review the “Risk Factors” section or other sections of, or incorporated by reference to, the Company’s Annual Report on Form 10-K filed February 16, 2024. All forward-looking statements attributable to either Holdings or CUSA or persons acting on our behalf, are expressly qualified in their entirety by such risk factors. Forward-looking statements contained in this Form 10-Q reflect the views of Holdings and CUSA only as of the date of this Form 10-Q. Neither Holdings nor CUSA undertake any obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Unless the context otherwise requires, all references to “we,” “our,” “us,” “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries, and all references to CUSA relate to Cinemark USA, Inc. and its consolidated subsidiaries. All references to Latin America relate to Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Paraguay.

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data, unaudited)


	June 30,			December 31,
	2024			2023
Assets
Current assets
Cash and cash equivalents	$	788.8		$	849.1
Inventories		26.5			23.3
Accounts receivable		92.7			80.4
Current income tax receivable		48.7			56.7
Prepaid expenses and other		51.7			50.5
Total current assets		1,008.4			1,060.0
Theatre properties and equipment, net		1,125.8			1,161.7
Operating lease right-of-use assets, net		990.2			986.4
Other long-term assets
Goodwill		1,243.9			1,251.0
Intangible assets, net		301.5			302.8
Investment in NCMI		19.2			18.1
Investments in affiliates		27.0			23.6
Long-term deferred tax asset		34.3			7.7
Deferred charges and other assets, net		35.9			25.5
Total other long-term assets		1,661.8			1,628.7
Total assets	$	4,786.2		$	4,836.8
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7.6		$	7.8
Current portion of operating lease obligations		210.5			212.5
Current portion of finance lease obligations		15.9			14.0
Current income tax payable		2.3			4.2
Accounts payable and accrued expenses		544.2			491.8
Total current liabilities		780.5			730.3
Long-term liabilities
Long-term debt, less current portion		2,242.8			2,391.3
Operating lease obligations, less current portion		850.9			853.3
Finance lease obligations, less current portion		92.2			73.8
Long-term deferred tax liability		30.3			51.7
Long-term liability for uncertain tax positions		49.8			48.0
NCM screen advertising advances		323.8			328.4
Other long-term liabilities		40.9			41.2
Total long-term liabilities		3,630.7			3,787.7
Equity
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock, $0.001 par value: 300,000,000 shares authorized, 128,696,154 shares issued and 122,387,242 shares outstanding at June 30, 2024 and 127,598,774 shares issued and 121,596,206 shares outstanding at December 31, 2023		0.1			0.1
Additional paid-in-capital		1,260.0			1,244.3
Treasury stock, 6,308,912 and 6,002,568 shares, at cost, at June 30, 2024 and December 31, 2023, respectively		(102.7	)		(98.3	)
Accumulated deficit		(401.8	)		(472.4	)
Accumulated other comprehensive loss		(389.8	)		(363.9	)
Total Cinemark Holdings, Inc.'s stockholders' equity		365.8			309.8
Noncontrolling interests		9.2			9.0
Total equity		375.0			318.8
Total liabilities and equity	$	4,786.2		$	4,836.8

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except per share data, unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Revenue
Admissions	$	365.8		$	478.4		$	655.6		$	789.4
Concession		292.9			373.4			517.1			609.2
Other		75.5			90.5			140.7			154.4
Total revenue	$	734.2		$	942.3		$	1,313.4		$	1,553.0
Cost of operations
Film rentals and advertising		204.0			278.0			358.3			444.7
Concession supplies		56.6			67.4			100.6			111.0
Salaries and wages		97.3			112.1			184.2			198.3
Facility lease expense		81.5			87.0			158.8			166.5
Utilities and other		104.7			120.2			205.1			224.0
General and administrative expenses		55.7			50.0			104.6			96.5
Depreciation and amortization		49.8			52.8			99.2			107.7
Impairment of long-lived and other assets		—			9.4			—			10.1
Loss (gain) on disposal of assets and other		1.7			(3.0	)		2.1			(2.7	)
Total cost of operations		651.3			773.9			1,212.9			1,356.1
Operating income		82.9			168.4			100.5			196.9
Other income (expense)
Interest expense		(34.6	)		(37.1	)		(72.3	)		(73.9	)
Interest income		12.5			13.0			26.1			24.9
Loss on debt amendments and extinguishments		(2.5	)		(10.7	)		(2.5	)		(10.7	)
Foreign currency exchange and other related loss		(6.3	)		(6.2	)		(4.9	)		(8.4	)
Interest expense - NCM		(5.6	)		(5.7	)		(11.1	)		(11.4	)
Equity in income (loss) of affiliates		2.5			1.8			6.3			(0.3	)
Net (loss) gain on investment in NCMI		(3.2	)		9.2			1.2			9.2
Total other expense		(37.2	)		(35.7	)		(57.2	)		(70.6	)
Income before income taxes		45.7			132.7			43.3			126.3
Income tax (benefit) expense		(0.9	)		12.3			(28.6	)		8.4
Net income	$	46.6		$	120.4		$	71.9		$	117.9
Less: Net income attributable to noncontrolling interests		0.8			1.3			1.3			1.9
Net income attributable to Cinemark Holdings, Inc.	$	45.8		$	119.1		$	70.6		$	116.0

Weighted average shares outstanding
Basic		119.9			119.1			119.7			118.9
Diluted		153.4			151.7			153.3			151.5
Income per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic	$	0.37		$	0.98		$	0.58		$	0.96
Diluted	$	0.32		$	0.80		$	0.51		$	0.82

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions, unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Net income	$	46.6		$	120.4		$	71.9		$	117.9
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements		0.3			2.6			3.8			(0.8	)
Foreign currency translation adjustments		(12.1	)		4.1			(22.9	)		12.2
Total other comprehensive (loss) income, net of tax	$	(11.8	)	$	6.7		$	(19.1	)	$	11.4
Total comprehensive income, net of tax		34.8			127.1			52.8			129.3
Comprehensive income attributable to noncontrolling interests		(0.8	)		(1.3	)		(1.3	)		(1.9	)
Comprehensive income attributable to Cinemark Holdings, Inc.	$	34.0		$	125.8		$	51.5		$	127.4

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in millions, unaudited)


																Total
													Accumulated			Cinemark
	Common Stock							Additional					Other			Holdings, Inc.'s
	Shares				Treasury			Paid-in-		Accumulated			Comprehensive			Stockholders’			Noncontrolling			Total
	Issued		Amount		Stock			Capital		Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2024		127.6	$	0.1	$	(98.3	)	$	1,244.3	$	(472.4	)	$	(363.9	)	$	309.8		$	9.0		$	318.8
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the three months ended March 31, 2024		—		—		(4.2	)		—		—			—			(4.2	)		—			(4.2	)
Issuance of stock upon vesting of performance stock units		0.1		—		—			—		—			—			—			—			—
Issuance of share-based awards and share-based awards compensation expense		0.9	—		—				6.4		—			—			6.4			—			6.4
Net income		—	—		—				—		24.8			—			24.8			0.5			25.3
Distributions to noncontrolling interests		—		—		—			—		—			—			—			(0.5	)		(0.5	)
Amortization of accumulated gains for amended swap agreements		—	—		—				—		—			(3.1	)		(3.1	)		—			(3.1	)
Other comprehensive loss		—	—		—				—		—			(7.3	)		(7.3	)		—			(7.3	)
Balance at March 31, 2024		128.6	$	0.1		(102.5	)	$	1,250.7	$	(447.6	)	$	(374.3	)	$	326.4		$	9.0		$	335.4
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the three months ended June 30, 2024		—		—		(0.2	)		—		—			—			(0.2	)		—			(0.2	)
Issuance of share-based awards and share-based awards compensation expense		0.1		—		—			9.3		—			—			9.3			—			9.3
Net income		—		—		—			—		45.8			—			45.8			0.8			46.6
Distributions to noncontrolling interests		—		—		—			—		—			—			—			(0.6	)		(0.6	)
Amortization of accumulated gains for amended swap agreements		—		—		—			—		—			(3.7	)		(3.7	)		—			(3.7	)
Other comprehensive loss		—		—		—			—		—			(11.8	)		(11.8	)		—			(11.8	)
Balance at June 30, 2024		128.7	$	0.1	$	(102.7	)	$	1,260.0	$	(401.8	)	$	(389.8	)	$	365.8		$	9.2		$	375.0

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY, CONT’D

(in millions, unaudited)


																Total
													Accumulated			Cinemark
	Common Stock							Additional					Other			Holdings, Inc's
	Shares				Treasury			Paid-in-		Accumulated			Comprehensive			Stockholders’			Noncontrolling			Total
	Issued		Amount		Stock			Capital		Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2023		126.1	$	0.1	$	(95.4	)	$	1,219.3	$	(660.6	)	$	(353.2	)	$	110.2		$	9.3		$	119.5
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the three months ended March 31, 2023		—		—		(2.1	)		—		—			—			(2.1	)		—			(2.1	)
Issuance of stock upon vesting of performance stock units		0.1		—		—			—		—			—			—			—			—
Issuance of share-based awards and share-based awards compensation expense		1.3		—		—			5.7		—			—			5.7			—			5.7
Net (loss) income		—		—		—			—		(3.1	)		—			(3.1	)		0.6			(2.5	)
Amortization of accumulated gains for amended swap agreements		—		—		—			—		—			(1.5	)		(1.5	)		—			(1.5	)
Other comprehensive income		—		—		—			—		—			4.7			4.7			—			4.7
Balance at March 31, 2023		127.5	$	0.1		(97.5	)	$	1,225.0	$	(663.7	)	$	(350.0	)	$	113.9		$	9.9		$	123.8
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the three months ended June 30, 2023		—		—		(0.3	)		—		—			—			(0.3	)		—			(0.3	)
Issuance of share-based awards and share-based awards compensation expense		0.1		—		—			6.8		—			—			6.8			—			6.8
Net income		—		—		—			—		119.1			—			119.1			1.3			120.4
Distributions to noncontrolling interests		—		—		—			—		—			—			—			(1.1	)		(1.1	)
Amortization of accumulated gains for amended swap agreements		—		—		—			—		—			(1.5	)		(1.5	)		—			(1.5	)
Other comprehensive income		—		—		—			—		—			6.7			6.7			—			6.7
Balance at June 30, 2023		127.6	$	0.1	$	(97.8	)	$	1,231.8	$	(544.6	)	$	(344.8	)	$	244.7		$	10.1		$	254.8

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions, unaudited)


	Six Months Ended June 30,
	2024			2023
Operating activities
Net income	$	71.9		$	117.9
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		98.1			106.6
Amortization of intangible and other assets		1.1			1.1
Loss on debt amendments and extinguishments		2.5			10.7
Amortization of original issue discount and debt issuance costs		4.7			5.3
Interest accrued on NCM screen advertising advances		11.1			11.4
Amortization of NCM screen advertising advances and other deferred revenue		(16.2	)		(16.2	)
Amortization of accumulated gains for amended swap agreements		(6.8	)		(3.1	)
Impairment of long-lived and other assets		—			10.1
Share-based awards compensation expense		15.7			12.5
Loss (gain) on disposal of assets and other		2.1			(2.7	)
Net gains on investment in NCMI		(1.2	)		(9.2	)
Non-cash rent expense		(7.6	)		(8.4	)
Equity in (income) loss of affiliates		(6.3	)		0.3
Deferred income tax (benefit) expense		(46.7	)		2.0
Distributions from equity investees		2.9			1.6
Changes in assets and liabilities and other		36.9			11.2
Net cash provided by operating activities		162.2			251.1

Investing activities
Additions to theatre properties and equipment		(47.2	)		(54.6	)
Proceeds from sale of theatre properties and equipment and other		0.2			—
Proceeds from redemption of common units of NCM		0.6			—
Net cash used for investing activities		(46.4	)		(54.6	)

Financing activities
Proceeds from amendment of senior secured credit facility		—			640.2
Repayment of term loan upon amendment of senior secured credit facility		—			(624.9	)
Redemption of 8.75% Secured Notes		(150.0	)		(102.2	)
Payment of debt issuance costs		(0.8	)		(7.5	)
Payment of fees on amendments of senior secured credit facility		(0.3	)		(2.6	)
Other repayments of long-term debt		(3.9	)		(6.4	)
Restricted stock withholdings for payroll taxes		(4.4	)		(2.4	)
Payments on finance leases		(7.5	)		(7.1	)
Other financing activities		(1.2	)		2.1
Net cash used for financing activities		(168.1	)		(110.8	)

Effect of exchange rate changes on cash and cash equivalents		(8.0	)		(2.2	)

(Decrease) increase in cash and cash equivalents		(60.3	)		83.5

Cash and cash equivalents:
Beginning of period		849.1			674.5
End of period	$	788.8		$	758.0

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the condensed consolidated financial statements.

* * * * * * * *

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data, unaudited)


	June 30,			December 31,
	2024			2023
Assets
Current assets
Cash and cash equivalents	$	554.8		$	612.4
Inventories		26.5			23.3
Accounts receivable		91.7			78.2
Current income tax receivable		47.7			56.1
Prepaid expenses and other		51.6			50.5
Accounts receivable from parent		65.7			58.6
Total current assets		838.0			879.1
Theatre properties and equipment, net		1,125.8			1,161.7
Operating lease right-of-use assets, net		990.2			986.4
Other long-term assets
Goodwill		1,243.9			1,251.0
Intangible assets, net		301.5			302.8
Investment in NCMI		19.2			18.1
Investments in affiliates		27.0			23.6
Long-term deferred tax asset		34.3			7.7
Deferred charges and other assets, net		35.9			25.5
Total other long-term assets		1,661.8			1,628.7
Total assets	$	4,615.8		$	4,655.9
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7.6		$	7.8
Current portion of operating lease obligations		210.5			212.5
Current portion of finance lease obligations		15.9			14.0
Current income tax payable		2.3			4.2
Accounts payable and accrued expenses		536.0			483.9
Total current liabilities		772.3			722.4
Long-term liabilities
Long-term debt, less current portion		1,786.7			1,936.8
Operating lease obligations, less current portion		850.9			853.3
Finance lease obligations, less current portion		92.2			73.8
Long-term deferred tax liability		32.1			51.7
Long-term liability for uncertain tax positions		49.8			48.0
NCM screen advertising advances		323.8			328.4
Other long-term liabilities		40.9			41.2
Total long-term liabilities		3,176.4			3,333.2
Equity
Cinemark USA, Inc.'s stockholder's equity:
Class A common stock, $0.01 par value: 10,000,000 shares authorized, 1,500 shares issued and outstanding		—			—
Class B common stock, no par value: 1,000,000 shares authorized, 239,893 shares issued and 182,648 shares outstanding		49.5			49.5
Treasury stock, 57,245 Class B shares at cost		(24.2	)		(24.2	)
Additional paid-in-capital		1,518.3			1,503.3
Accumulated deficit		(493.1	)		(570.6	)
Accumulated other comprehensive loss		(392.6	)		(366.7	)
Total Cinemark USA, Inc.'s stockholder's equity		657.9			591.3
Noncontrolling interests		9.2			9.0
Total equity		667.1			600.3
Total liabilities and equity	$	4,615.8		$	4,655.9

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Revenue
Admissions	$	365.8		$	478.4		$	655.6		$	789.4
Concession		292.9			373.4			517.1			609.2
Other		75.5			90.5			140.7			154.4
Total revenue	$	734.2		$	942.3		$	1,313.4		$	1,553.0
Cost of operations
Film rentals and advertising		204.0			278.0			358.3			444.7
Concession supplies		56.6			67.4			100.6			111.0
Salaries and wages		97.3			112.1			184.2			198.3
Facility lease expense		81.5			87.0			158.8			166.5
Utilities and other		104.7			120.2			205.1			224.0
General and administrative expenses		54.7			49.1			102.7			94.7
Depreciation and amortization		49.8			52.8			99.2			107.7
Impairment of long-lived and other assets		—			9.4			—			10.1
Loss (gain) on disposal of assets and other		1.7			(3.0	)		2.1			(2.7	)
Total cost of operations		650.3			773.0			1,211.0			1,354.3
Operating income		83.9			169.3			102.4			198.7
Other income (expense)
Interest expense		(28.6	)		(31.0	)		(60.2	)		(61.8	)
Interest income		9.4			10.1			19.7			19.3
Loss on debt amendments and extinguishments		(2.5	)		(10.7	)		(2.5	)		(10.7	)
Foreign currency exchange and other related loss		(6.3	)		(6.2	)		(4.9	)		(8.4	)
Interest expense - NCM		(5.6	)		(5.7	)		(11.1	)		(11.4	)
Equity in income (loss) of affiliates		2.5			1.8			6.3			(0.3	)
Net (loss) gain on investment in NCMI		(3.2	)		9.2			1.2			9.2
Total other expense		(34.3	)		(32.5	)		(51.5	)		(64.1	)
Income before income taxes		49.6			136.8			50.9			134.6
Income tax (benefit) expense		(1.3	)		15.3			(27.9	)		6.8
Net income	$	50.9		$	121.5		$	78.8		$	127.8
Less: Net income attributable to noncontrolling interests		0.8			1.3			1.3			1.9
Net income attributable to Cinemark USA, Inc.	$	50.1		$	120.2		$	77.5		$	125.9

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions, unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Net income	$	50.9		$	121.5		$	78.8		$	127.8
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements		0.3			2.6			3.8			(0.8	)
Foreign currency translation adjustments		(12.1	)		4.1			(22.9	)		12.2
Total other comprehensive (loss) income, net of tax	$	(11.8	)	$	6.7		$	(19.1	)	$	11.4
Total comprehensive income, net of tax		39.1			128.2			59.7			139.2
Comprehensive income attributable to noncontrolling interests		(0.8	)		(1.3	)		(1.3	)		(1.9	)
Comprehensive income attributable to Cinemark USA, Inc.	$	38.3		$	126.9		$	58.4		$	137.3

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in millions, unaudited)


																				Total
	Class A				Class B												Accumulated			Cinemark
	Common Stock				Common Stock							Additional					Other			USA, Inc's
	Shares				Shares				Treasury			Paid-in-		Accumulated			Comprehensive			Stockholder's			Noncontrolling			Total
	Issued		Amount		Issued		Amount		Stock			Capital		Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2024		—	$	—	0.2		$	49.5	$	(24.2	)	$	1,503.3	$	(570.6	)	$	(366.7	)	$	591.3		$	9.0		$	600.3
Share-based awards compensation expense		—		—		—		—		—			6.0		—			—			6.0			—			6.0
Net income		—		—		—		—		—			—		27.4			—			27.4			0.5			27.9
Distributions to noncontrolling interests		—		—		—		—		—			—		—			—			—			(0.5	)		(0.5	)
Amortization of accumulated gains for amended swap agreements		—		—		—		—		—			—		—			(3.1	)		(3.1	)		—			(3.1	)
Other comprehensive loss		—		—		—		—		—			—		—			(7.3	)		(7.3	)		—			(7.3	)
Balance at March 31, 2024		—	$	—		0.2	$	49.5	$	(24.2	)	$	1,509.3	$	(543.2	)	$	(377.1	)	$	614.3		$	9.0		$	623.3
Share-based awards compensation expense		—		—		—		—		—			9.0		—			—			9.0			—			9.0
Net income		—		—		—		—		—			—		50.1			—			50.1			0.8			50.9
Distributions to noncontrolling interests		—		—		—		—		—			—		—			—			—			(0.6	)		(0.6	)
Amortization of accumulated gains for amended swap agreements		—		—		—		—		—			—		—			(3.7	)		(3.7	)		—			(3.7	)
Other comprehensive loss		—		—		—		—		—			—		—			(11.8	)		(11.8	)		—			(11.8	)
Balance at June 30, 2024		—	$	—		0.2	$	49.5	$	(24.2	)	$	1,518.3	$	(493.1	)	$	(392.6	)	$	657.9		$	9.2		$	667.1

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY, CONT’D

(in millions, unaudited)


																				Total
	Class A				Class B												Accumulated			Cinemark
	Common Stock				Common Stock							Additional					Other			USA, Inc's
	Shares				Shares				Treasury			Paid-in-		Accumulated			Comprehensive			Stockholder's			Noncontrolling			Total
	Issued		Amount		Issued		Amount		Stock			Capital		Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2023		—	$	—	0.2		$	49.5	$	(24.2	)	$	1,479.5	$	(775.9	)	$	(356.3	)	$	372.6		$	9.3		$	381.9
Share-based awards compensation expense		—		—		—		—		—			5.4		—			—			5.4			—			5.4
Net income		—		—		—		—		—			—		5.7			—			5.7			0.6			6.3
Amortization of accumulated gains for amended swap agreements		—		—		—		—		—			—		—			(1.5	)		(1.5	)		—			(1.5	)
Other comprehensive income		—		—		—		—		—			—		—			4.7			4.7			—			4.7
Balance at March 31, 2023		—	$	—		0.2	$	49.5	$	(24.2	)	$	1,484.9	$	(770.2	)	$	(353.1	)	$	386.9		$	9.9		$	396.8
Share-based awards compensation expense		—		—		—		—		—			6.5		—			—			6.5			—			6.5
Net income		—		—		—		—		—			—		120.2			—			120.2			1.3			121.5
Distributions to noncontrolling interests		—		—		—		—		—			—		—			—			—			(1.1	)		(1.1	)
Amortization of accumulated gains for amended swap agreements		—		—		—		—		—			—		—			(1.5	)		(1.5	)		—			(1.5	)
Other comprehensive income		—		—		—		—		—			—		—			6.7			6.7			—			6.7
Balance at June 30, 2023		—	$	—		0.2	$	49.5	$	(24.2	)	$	1,491.4	$	(650.0	)	$	(347.9	)	$	518.8		$	10.1		$	528.9

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions, unaudited)


	Six Months Ended June 30,
	2024			2023
Operating activities
Net income	$	78.8		$	127.8
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		98.1			106.6
Amortization of intangible and other assets		1.1			1.1
Loss on debt amendments and extinguishments		2.5			10.7
Amortization of original issue discount and debt issuance costs		3.0			3.5
Interest accrued on NCM screen advertising advances		11.1			11.4
Amortization of NCM screen advertising advances and other deferred revenue		(16.2	)		(16.2	)
Amortization of accumulated gains for amended swap agreements		(6.8	)		(3.1	)
Impairment of long-lived and other assets		—			10.1
Share-based awards compensation expense		15.0			11.9
Loss (gain) on disposal of assets and other		2.1			(2.7	)
Net gains on investment in NCMI		(1.2	)		(9.2	)
Non-cash rent expense		(7.6	)		(8.4	)
Equity in (income) loss of affiliates		(6.3	)		0.3
Deferred income tax (benefit) expense		(44.9	)		4.3
Distributions from equity investees		2.9			1.6
Changes in assets and liabilities and other		33.3			6.3
Net cash provided by operating activities		164.9			256.0

Investing activities
Additions to theatre properties and equipment		(47.2	)		(54.6	)
Proceeds from sale of theatre properties and equipment and other		0.2			—
Proceeds from redemption of common units of NCM		0.6			—
Net cash used for investing activities		(46.4	)		(54.6	)

Financing activities
Proceeds from amendment of senior secured credit facility		—			640.2
Repayment of term loan upon amendment of senior secured facility		—			(624.9	)
Redemption of 8.75% Secured Notes		(150.0	)		(102.2	)
Payment of debt issuance costs		(0.8	)		(7.5	)
Payment of fees on amendments of senior secured credit facility		(0.3	)		(2.6	)
Repayments of long-term debt		(3.9	)		(6.4	)
Restricted stock withholdings for payroll taxes		(4.4	)		(2.4	)
Payments on finance leases		(7.5	)		(7.1	)
Other financing activities		(1.2	)		2.1
Net cash used for financing activities		(168.1	)		(110.8	)

Effect of exchange rate changes on cash and cash equivalents		(8.0	)		(2.2	)

(Decrease) increase in cash and cash equivalents		(57.6	)		88.4

Cash and cash equivalents:
Beginning of period		612.4			427.3
End of period	$	554.8		$	515.7

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the condensed consolidated financial statements.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

The Company and Basis of Presentation

Cinemark Holdings, Inc. (“Holdings”) is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. (“CUSA”). Holdings consolidates CUSA and its subsidiaries for financial statement purposes, and CUSA’s operating revenue and operating expenses comprise nearly 100% of Holdings’ revenue and operating expenses. As such, the following Notes to Condensed Consolidated Financial Statements relate to Holdings and CUSA and their respective consolidated subsidiaries in all material respects, unless otherwise noted. Where it is important to distinguish between Holdings and CUSA, specific reference is made to either Holdings or CUSA. Otherwise, all references to “we,” “our,” “us,” and “the Company” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries. We operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay.

The accompanying condensed consolidated balance sheets of Holdings and CUSA as of December 31, 2023, each of which were derived from audited financial statements, and the unaudited condensed consolidated financial statements of Holdings and CUSA, respectively, have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates.

We reclassified the long-term deferred tax asset of $7.7 in the condensed consolidated balance sheets of Holdings and CUSA for the year ended December 31, 2023 from “Deferred charges and other assets, net” to “Long-term deferred tax asset” to conform to the current period presentation.

These condensed consolidated financial statements of Holdings and CUSA should be read in conjunction with the audited annual consolidated financial statements of Holdings and CUSA and the notes thereto for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K filed with the SEC on February 16, 2024. Operating results for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be achieved for the full year.

New Accounting Pronouncements

ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The purpose of ASU 2023-07 is to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses to enable investors to better understand an entity’s overall performance and assess potential future cash flows. In addition, the amendments of ASU 2023-07 enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The amendments in ASU 2023-07 are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting the additional disclosure requirements of ASU 2023-07.

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The purpose of ASU 2023-09 is to enhance the transparency and decision usefulness of income tax disclosures in order to provide information to better assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in ASU-2023-09 require that public entities, on an annual basis, (i) disclose specific categories in the income tax rate reconciliation and (ii) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). The amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting the additional disclosure requirements of ASU 2023-09.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Lease Accounting

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented.


		Three Months Ended				Six Months Ended
		June 30,				June 30,
Lease Cost	Classification	2024		2023		2024		2023
Operating lease costs
Equipment (1)	Utilities and other	$	0.8	$	1.3	$	1.6	$	2.7
Real Estate (1)	Facility lease expense		84.0		90.8		164.6		172.9
Total operating lease costs		$	84.8	$	92.1	$	166.2	$	175.6

Finance lease costs
Amortization of leased assets	Depreciation and amortization	$	3.4	$	3.0	$	6.5	$	6.0
Interest on lease liabilities	Interest expense		1.5		1.3		2.9		2.5
Total finance lease costs		$	4.9	$	4.3	$	9.4	$	8.5

(1)

Includes short-term lease payments, variable lease payments and office lease payments reflected in general and administrative expense as set forth in the following table for the periods presented:


		Three Months Ended				Six Months Ended
		June 30,				June 30,
Lease Cost	Classification	2024		2023		2024		2023
Operating lease costs
Equipment - Short-term and variable lease payments	Utilities and other	$	0.7	$	1.2	$	1.4	$	2.5
Real Estate - Variable lease payments (1)	Facility lease expense	$	16.5	$	20.1	$	28.7	$	32.8
Real Estate - Office leases	General and administrative	$	0.3	$	0.3	$	0.6	$	0.6

(1) Represents lease payments that are based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs.

The following table represents the minimum cash lease payments as included in the measurement of lease liabilities and the non-cash addition of lease right-of-use assets for the periods presented.


	Six Months Ended
	June 30,
Other Information	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Cash outflows for operating leases	$	136.1	$	140.3
Cash outflows for finance leases - operating activities	$	2.9	$	2.5
Cash outflows for finance leases - financing activities	$	7.5	$	7.1
Non-cash amount of right-of-use assets obtained in exchange for:
Operating lease liability additions, net	$	110.5	$	46.3
Finance lease liability additions, net	$	27.9	$	—

As of June 30, 2024, the Company had signed lease agreements with total non-cancelable lease payments of approximately $37.7 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, Leases, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of June 30, 2024.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Revenue Recognition

The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime, right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer at the theatre, or if purchased online in advance, once the consumer’s order is fulfilled. Other revenue primarily consists of screen advertising, screen rental revenue, promotional income, studio trailer placements and transactional fees. Except for National CineMedia, LLC (“NCM”) screen advertising advances discussed in Note 8, these revenues are generally recognized when the Company has fulfilled its performance obligations by providing the services specified in each contract.

The Company sells gift cards, and prepaid and discount ticket vouchers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and ticket vouchers is recognized when they are redeemed for movie tickets and the movie showtime has passed. The Company generally records breakage revenue on gift cards and ticket vouchers based on redemption activity and historical experience associated with unused balances.

The Company offers a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. The Company also offers monthly subscription fee programs in several of its international locations where customers can pay a monthly or annual fee to receive benefits such as a free monthly ticket. The Company records subscription program fees as deferred revenue and records admissions revenue when the showtime for a movie ticket purchased with a credit has passed. The Company records breakage revenue based upon redemption of subscription credits and historical experience with unused credits.

The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, the Company recognizes the fee collected as other revenue on a straight-line basis over the annual membership period. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognizes the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue based upon redemption of loyalty points and historical experience with unused points.

Accounts receivable as of June 30, 2024 and December 31, 2023 included approximately $31.0 and $31.6, respectively, of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the six months ended June 30, 2024.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Disaggregation of Revenue

The following tables present revenue for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.


	Three Months Ended						Six Months Ended
	June 30, 2024						June 30, 2024
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Admissions revenue	$	287.4	$	78.4	$	365.8	$	519.2	$	136.4	$	655.6
Concession revenue		231.4		61.5		292.9		410.0		107.1		517.1
Screen advertising, screen rental and promotional revenue (2)		22.3		12.7		35.0		43.3		23.4		66.7
Other revenue		30.9		9.6		40.5		56.5		17.5		74.0
Total revenue	$	572.0	$	162.2	$	734.2	$	1,029.0	$	284.4	$	1,313.4


	Three Months Ended						Six Months Ended
	June 30, 2023						June 30, 2023
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Admissions revenue	$	373.4	$	105.0	$	478.4	$	618.1	$	171.3	$	789.4
Concession revenue		296.3		77.1		373.4		483.1		126.1		609.2
Screen advertising, screen rental and promotional revenue (2)		24.7		13.5		38.2		46.5		22.8		69.3
Other revenue		40.5		11.8		52.3		66.3		18.8		85.1
Total revenue	$	734.9	$	207.4	$	942.3	$	1,214.0	$	339.0	$	1,553.0

(1)

U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented.

(2)

Amount includes amortization of NCM screen advertising advances. See Screen Advertising Advances and Other Deferred Revenue below.

The following tables present revenue for the periods indicated, disaggregated based on timing of recognition (as discussed above) and by reportable operating segment.


	Three Months Ended						Six Months Ended
	June 30, 2024						June 30, 2024
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	547.7	$	148.8	$	696.5	$	981.5	$	257.6	$	1,239.1
Goods and services transferred over time (2)		24.3		13.4		37.7		47.5		26.8		74.3
Total	$	572.0	$	162.2	$	734.2	$	1,029.0	$	284.4	$	1,313.4


	Three Months Ended						Six Months Ended
	June 30, 2023						June 30, 2023
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment (1)		Segment		Consolidated		Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	714.7	$	192.8	$	907.5	$	1,162.5	$	312.0	$	1,474.5
Goods and services transferred over time (2)		20.2		14.6		34.8		51.5		27.0		78.5
Total	$	734.9	$	207.4	$	942.3	$	1,214.0	$	339.0	$	1,553.0

(1)

U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented.

(2)

Amount includes amortization of NCM screen advertising advances. See Screen Advertising Advances and Other Deferred Revenue below.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Screen Advertising Advances and Other Deferred Revenue

The following table presents changes in the Company’s deferred revenue for the six months ended June 30, 2024.


	NCM screen advertising advances (1)			Other deferred revenue (2)
Balance at January 1, 2024	$	328.4		$	221.6
Amounts recognized as accounts receivable		—			11.7
Cash received from customers in advance		—			149.2
Common units received from NCM (see Note 8)		0.5			—
Interest accrued related to significant financing component		11.1			—
Revenue recognized during period		(16.2	)		(153.6	)
Foreign currency translation adjustments		—			(2.0	)
Balance at June 30, 2024	$	323.8		$	226.9

(1)

See Note 8 for the remaining maturity of NCM screen advertising advances as of June 30, 2024.

(2)

Includes liabilities associated with outstanding gift cards and ticket vouchers, points or rebates outstanding under the Company’s loyalty and subscription programs and revenue not yet recognized for screen advertising and other promotional activities. Amounts are classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of June 30, 2024 and when the Company expects to recognize this revenue.


	Twelve Months Ended June 30,
Remaining Performance Obligations	2025		2026		Thereafter		Total
Other deferred revenue	$	200.4	$	26.5	$	—	$	226.9

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Earnings Per Share

The following table presents computations of basic and diluted earnings per share for Holdings:


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023
Numerator:
Net income attributable to Cinemark Holdings, Inc.	$	45.8		$	119.1		$	70.6		$	116.0
Income allocated to participating share-based awards (1)		(0.9	)		(2.3	)		(1.2	)		(1.9	)
Basic net income attributable to common stockholders	$	44.9		$	116.8		$	69.4		$	114.1
Add: Interest expense on convertible notes, net of tax		4.7			4.6			9.4			9.8
Diluted net income attributable to common stockholders	$	49.6		$	121.4		$	78.8		$	123.9

Denominator:
Basic weighted average shares outstanding		119.9			119.1			119.7			118.9
Common equivalent shares for performance stock units		1.5			0.6			1.6			0.6
Common equivalent shares for convertible notes		32.0			32.0			32.0			32.0
Common equivalent shares for warrants (2)		—			—			—			—
Diluted weighted average shares outstanding		153.4			151.7			153.3			151.5

Basic earnings per share attributable to common stockholders	$	0.37		$	0.98		$	0.58		$	0.96
Diluted earnings per share attributable to common stockholders	$	0.32		$	0.80		$	0.51		$	0.82

(1)

For the three months ended June 30, 2024 and 2023, a weighted average of approximately 2.34 shares and 2.40 shares of restricted stock, respectively, were considered participating securities. For the six months ended June 30, 2024 and 2023, a weighted average of approximately 2.09 shares and 2.03 shares of restricted stock, respectively, were considered participating securities.

(2)

For all periods presented, diluted earnings per share excludes the warrants, as they would be anti-dilutive.

Share-based awards

Holdings considers its unvested restricted stock awards, which contain non-forfeitable rights to dividends, participating securities and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method. For the three and six months ended June 30, 2024 and 2023, diluted earnings per share using the treasury stock method was less dilutive than the two-class method; as such, only the two-class method has been included above.

Convertible notes, hedges and warrants

The 4.50% Convertible Senior Notes, discussed further in Note 14 of the Company’s Annual Report on Form 10-K filed February 16, 2024, may be considered dilutive in periods in which Holdings has net income. The impact of such dilution on earnings per share is calculated under the if-converted method, which requires that all of the shares of Holdings' common stock issuable upon conversion of the 4.50% Convertible Senior Notes be included in the calculation of diluted earnings per share assuming conversion at the beginning of the reporting period. Also, the interest expense, net of tax, related to the 4.50% Convertible Senior Notes is excluded from the calculation of diluted net income attributable to common stockholders assuming conversion of the 4.50% Convertible Senior Notes at the beginning of the reporting period.

The closing price of Holdings' common stock did not exceed the strike price of $18.66 per share (130% of the initial conversion price of $14.35 per share) during at least 20 of the last 30 trading days of the quarter ended June 30, 2024 and, therefore, the 4.50% Convertible Senior Notes will not be convertible during the third quarter of 2024. The if-converted value of the 4.50% Convertible Senior Notes, based on the weighted average closing price of Holdings common stock for the second quarter of 2024, exceeded the aggregate outstanding principal value of the notes by $87.5 as of June 30, 2024.

Holdings entered into hedge transactions with counterparties in connection with the issuance of the 4.50% Convertible Senior Notes. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

4.50% Convertible Senior Notes, the number of shares of Holdings' common stock underlying the 4.50% Convertible Notes, which initially gives Holdings the option to purchase approximately 32.0 shares of its common stock at a price of approximately $14.35 per share. Concurrently with entering into the convertible note hedge transactions, Holdings also entered into warrant transactions with each option counterparty whereby Holdings sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, up to the same number of shares of Holdings' common stock, which initially gives the option counterparties the option to purchase approximately 32.0 shares at a price of approximately $22.08 per share. The economic effect of these transactions is to effectively raise the strike price of the 4.50% Convertible Senior Notes from approximately $18.66 per share of Holdings' common stock to approximately $22.08 per share.

Sale of Subsidiary

During December 2022, the Company entered into a purchase and sale agreement for the sale of the stock of its Ecuador subsidiary and completed the sale in September 2023. The sale of the Ecuador subsidiary did not qualify as discontinued operations since it did not represent a strategic shift in the Company’s operations that will have a major effect on its results and operations. The following table summarizes total revenue and operating income for the Ecuador subsidiary for the three and six months ended June 30, 2023.


	Three Months Ended June 30, 2023		Six Months Ended June 30, 2023
Total revenue	$	6.1	$	9.6
Operating income	$	1.6	$	1.5

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Long-Term Debt

Long-term debt of Holdings and CUSA consisted of the following for the periods presented:


	June 30,		December 31,
	2024		2023
Cinemark Holdings, Inc. 4.50% convertible senior notes due August 2025	$	460.0	$	460.0
Cinemark USA, Inc. term loan due May 2030		641.9		645.1
Cinemark USA, Inc. 8.75% senior secured notes due May 2025		—		150.0
Cinemark USA, Inc. 5.875% senior notes due March 2026		405.0		405.0
Cinemark USA, Inc. 5.25% senior notes due July 2028		765.0		765.0
Other		5.5		7.0
Total long-term debt carrying value (1)	$	2,277.4	$	2,432.1
Less: Current portion		7.6		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization (1)		27.0		33.0
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount (1)	$	2,242.8	$	2,391.3

(1)

The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 4.50% Convertible Senior Notes due August 2025 and the related debt issuance costs. The following table sets forth, as of the periods indicated, the total long-term debt carrying value, current portion of long-term debt and debt issuance costs, net of amortization, for CUSA.


	June 30,		December 31,
	2024		2023
Total long-term debt carrying value	$	1,817.4	$	1,972.1
Less: Current portion		7.6		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization		23.1		27.5
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	$	1,786.7	$	1,936.8

Senior Secured Credit Facility

On May 28, 2024, CUSA amended and restated its senior secured credit facility (the “Credit Agreement”) to reduce the rate at which the term loan bears interest by 0.50% and reset the 101% soft call for another six months. CUSA incurred a total of approximately $1.0 in debt issuance costs in connection with the amendment, which are reflected in the condensed consolidated financial statements as follows: (i) $0.8 in debt issuance costs were capitalized and are reflected as a reduction of “Long-term debt, less current portion” on the Company’s condensed consolidated balance sheet; and (ii) $0.2 of legal and other fees are included in “Loss on debt amendments and extinguishments” in the Company’s condensed consolidated statement of income for the three and six months ended June 30, 2024. As a result of the amendment, CUSA also wrote-off $1.3 of unamortized debt issuance costs and original issue discount associated with exiting lenders of the amended Credit Agreement, which is reflected in “Loss on debt amendments and extinguishments” in the Company’s condensed consolidated statement of income for the three and six months ended June 30, 2024.

As of June 30, 2024, there was $641.9 outstanding under the term loan and no borrowings were outstanding under the revolving credit line. Under the Credit Agreement, principal payments of $1.6 are due on the term loan quarterly through March 31, 2030, with a final principal payment of the remaining unpaid principal due on May 24, 2030. The average interest rate on outstanding term loan borrowings under the Credit Agreement as of June 30, 2024 was approximately 7.1% per annum, after giving effect to the interest rate swap agreements discussed below.

8.75% Secured Notes

On May 1, 2024, CUSA redeemed the remaining $150.0 in outstanding principal amount of the 8.75% Secured Notes, at par, plus accrued interest thereon for $156.6 in cash. As a result of the redemption, the indenture governing the 8.75% Secured Notes was fully satisfied and discharged. CUSA recognized a loss on extinguishment of debt of $1.0 related to the write-off of unamortized debt issuance costs, which is reflected in “Loss on debt amendments and extinguishments” in the Company’s condensed consolidated statement of income for the three and six months ended June 30, 2024. For additional discussion of the 8.75% Secured Notes, see Note 14 to the Company’s consolidated financial statements for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K filed February 16, 2024.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Interest Rate Swap Agreements

The Company’s interest rate swap agreements are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting.

Effective January 31, 2024, the Company amended and extended one of its then existing $137.5 notional amount interest rate swap agreements to amend the pay rate and extend the maturity date to December 31, 2027. Effective February 29, 2024, the Company amended and extended its other then existing $137.5 notional amount interest rate swap agreement to amend the pay rate and extend the maturity to December 31, 2026. Upon amending each of the interest rate swap agreements, the Company determined that the interest payments hedged with the respective agreements are still probable to occur, therefore the aggregate gains that accumulated on the swaps prior to the amendments of $7.0 are being amortized to interest expense through the maturity date of the swaps.

Below is a summary of the Company's interest rate swap agreements, which are designated as cash flow hedges, as of June 30, 2024:


Notional					Estimated
Amount		Pay Rate	Receive Rate	Expiration Date	Fair Value (1)
$	137.5	3.21%	1-Month Term SOFR	December 31, 2026	$	3.9
$	175.0	3.20%	1-Month Term SOFR	December 31, 2026		5.0
$	137.5	3.17%	1-Month Term SOFR	December 31, 2027		4.6
				Total	$	13.5

(1)

Approximately $7.9 of the total is included in prepaid expenses and other and $5.6 is included in deferred charges and other assets, net on the condensed consolidated balance sheet as of June 30, 2024.

The fair values of the interest rate swaps are recorded on Holdings’ and CUSA’s condensed consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparties to the interest rate swap agreements and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company's measurements are based on observable market data, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Fair Value of Long-Term Debt

The Company estimates the fair value of its long-term debt primarily based on observable market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC 820-10-35, Fair Value Measurement. The table below presents the fair value of the Company's long-term debt as of the periods presented:


	As of
	June 30, 2024		December 31, 2023
Holdings fair value (1)	$	2,517.4	$	2,460.3
CUSA fair value	$	1,788.6	$	1,903.8

(1)

The fair value of the 4.50% convertible senior notes was $728.8 and $556.5 as of June 30, 2024 and December 31, 2023, respectively.

Investment in National CineMedia Inc.

NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company has an investment in NCM’s parent National CineMedia, Inc. (“NCMI”). The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides screen advertising to the Company’s theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for the Company’s theatres. See further discussion below under Exhibitor Services Agreement.

Below is a summary of activity with NCMI and NCM included in each of Holdings' and CUSA's condensed consolidated financial statements:


	Investment in NCMI		NCM Screen Advertising Advances			Other Revenue			Interest Expense - NCM		Cash Received (4)

Balance at January 1, 2024	$	18.1	$	(328.4	)	$	—		$	—	$	—
Screen rental revenue earned under ESA (1)		—		—			(10.4	)		—		8.2
Interest accrued related to significant financing component		—		(11.1	)		—			11.1		—
Receipt of common units in NCM due to annual common unit adjustment (2)		—		(0.5	)		—			—		—
Change in unrealized gain on fair market adjustment of investment in NCMI (3)		1.1		—			—			—		—
Amortization of screen advertising advances		—		16.2			(16.2	)		—		—
Balance as of and for the six months ended June 30, 2024	$	19.2	$	(323.8	)	$	(26.6	)	$	11.1	$	8.2

(1)

Amounts include the per patron and per digital screen theatre access fees, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $3.7.

(2)

See Common Unit Adjustments below.

(3)

See Investment in National CineMedia below.

(4)

The Company had a receivable from NCM of $2.2 as of June 30, 2024.

Investment in National CineMedia

The Company accounts for its investment in NCMI in accordance with the guidance set forth in FASB ASC Topic 321 Investments - Equity Securities, which requires the Company to measure its investment in common stock of NCMI at fair value and recognize unrealized holding gains and losses on its investment in earnings. The Company recognized an unrealized loss of $3.3 and unrealized gain of $1.1 on its investment in NCMI in the Company’s condensed consolidated statement of income for the three and six months ended June 30, 2024, respectively. The Company recognized an unrealized gain of $9.2 on its investment in NCMI in the Company’s condensed consolidated statement of income for the three and six months ended June 30, 2023. During the first quarter of 2023, the Company accounted for its investment in NCMI under the equity method and therefore did not recognize unrealized holding gains and losses on its investment.

As of June 30, 2024, the Company owned approximately 4.4 shares of NCMI, which represented an interest in NCMI of approximately 4.5%.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

See Note 9 to the Company’s Annual Report on Form 10-K filed February 16, 2024 for additional discussion of the Company's investment in NCMI.

Common Unit Adjustments

Under the Common Unit Adjustment Agreement, the Company periodically receives consideration in the form of common units from NCM based on increases or decreases in the number of theatre screens operated and the impact of these theatres on total attendance. The common units received are recorded at estimated fair value as an increase in the Company's investment in NCM with an offset to NCM screen advertising advances. Each common unit from NCM is convertible to one share of NCMI.

During March 2024, NCM performed the annual common unit adjustment calculation for 2023 and as a result of the calculation, the Company received approximately 0.1 common units of NCM on April 1, 2024. The Company recorded the common units at their estimated fair value of $0.5 with a corresponding adjustment to NCM screen advertising advances. The fair value of the common units received was estimated based on the market price of NCMI’s common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.

On April 10, 2024, the Company delivered a redemption notice to NCM to redeem these common units in NCM for shares of NCMI common stock. On April 12, 2024, NCM delivered a notice to the Company that pursuant to its rights under the operating agreement, NCM would settle the Company’s redemption request with a cash settlement, effective on April 15, 2024, at a redemption price of approximately $4.95 per common unit, or approximately $0.6. The amount of the cash settlement represents the estimated fair value of the NCM common units based on the closing market price of NCMI’s common stock on April 10, 2024. During the three months ended June 30, 2024, as a result of the cash settlement, the Company recorded a reduction in its investment in NCM of $0.5 and a gain of $0.1 which is reflected in “Net (loss) gain on investment in NCMI” on the Company’s condensed consolidated statement of income (loss) for the three and six months ended June 30, 2024.

Exhibitor Services Agreement

As previously discussed, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. The Company receives a monthly theatre access fee for participation in the NCM network and also earns screen advertising or screen rental revenue on a per patron basis. See Note 9 to the Company’s Annual Report on Form 10-K filed February 16, 2024 for further discussion of the accounting for revenue earned under the ESA as well as the accounting related to NCM screen advertising advances.

The NCM screen advertising advances are recognized as revenue on a straight-line basis over the term of the ESA through February 2041. The table below summarizes when the Company expects to recognize this deferred revenue:


	Twelve Months Ended June 30,
Remaining Maturity	2025		2026		2027		2028		2029		Thereafter		Total
NCM screen advertising advances (1)	$	10.8	$	11.6	$	12.4	$	13.3	$	14.2	$	261.5	$	323.8

(1)

Amounts are net of the estimated interest to be accrued for the periods presented.

Significant Financing Component

As discussed in Note 9 to the Company’s Annual Report on Form 10-K filed February 16, 2024, the Company’s ESA with NCM includes an implied significant financing component, as per the guidance in ASC Topic 606, Revenue from Contracts with Customers. As a result of the significant financing component, the Company recognized incremental screen rental revenue and interest expense of $16.2 and $11.1, respectively, during the six months ended June 30, 2024 and incremental screen rental revenue and interest expense of $16.2 and $11.4, respectively, during the six months ended June 30, 2023. The interest expense was calculated using the Company's incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.3%.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Investments in Affiliates

Below is a summary of the activity for each of the Company’s affiliates and corresponding changes to the Company's investment balances during the six months ended June 30, 2024. See Note 10 to the consolidated financial statements in the Company’s Annual Report on Form 10-K filed February 16, 2024 for a further discussion of the Company’s investments in affiliates.


	AC JV, LLC			DCDC		FE Concepts		Total
Balance at January 1, 2024	$	3.4		$	2.1		18.1	$	23.6
Cash distributions received		(2.9	)		—		—		(2.9	)
Equity income		5.3			0.3		0.7		6.3
Balance at June 30, 2024	$	5.8		$	2.4	$	18.8	$	27.0

Transactions with Affiliates

Below is a summary of transactions with each of the Company’s affiliates for the three and six months ended June 30, 2024 and 2023:


		Three Months Ended				Six Months Ended
Investee	Transactions	June 30, 2024		June 30, 2023		June 30, 2024		June 30, 2023
AC JV, LLC	Event fees paid (1)	$	4.4	$	4.4	$	11.5	$	7.4
DCDC	Content delivery fees paid (1)	$	0.2	$	0.2	$	0.3	$	0.3

(1)

Included in film rentals and advertising costs on the condensed consolidated statements of income.

10.

Treasury Stock and Share-Based Awards

Treasury Stock - Holdings

Treasury stock represents shares of common stock repurchased by Holdings and not yet retired. The Company has applied the cost method in recording its treasury shares. Below is a summary of Holdings’ treasury stock activity for the six months ended June 30, 2024:


	Number of
	Treasury
	Shares		Cost
Balance at January 1, 2024		6.00	$	98.3
Restricted stock withholdings (1)		0.27		4.4
Restricted stock forfeitures (2)		0.04		—
Balance at June 30, 2024		6.31	$	102.7

(1)

Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and performance stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vesting dates, which ranged from $13.93 to $18.76 per share.

(2)

Holdings repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with its Long-Term Incentive Plan.

As of June 30, 2024, Holdings had no plans to retire any shares of treasury stock.

Restricted Stock

Below is a summary of restricted stock activity for the six months ended June 30, 2024:


	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2024		2.35		$	15.67
Granted		0.97			16.57
Vested		(0.88	)		15.95
Forfeited		(0.04	)		14.82
Outstanding and unvested at June 30, 2024		2.40		$	15.95

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

During the six months ended June 30, 2024, Holdings granted 1.0 shares of its restricted stock to its directors and certain CUSA employees. The fair value of the restricted stock granted was determined based on the closing price of Holdings' common stock on the grant dates, which ranged from $16.43 to $18.33 per share. Holdings assumed forfeiture rates for the restricted stock awards that ranged from 0% to 10%. The restricted stock granted during the six months ended June 30, 2024 vests over periods ranging from one to three years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Below is a summary of restricted stock award activity recorded for the periods indicated.


	Six Months Ended June 30,
	2024		2023
Compensation expense recognized during the period:
CUSA employees	$	7.8	$	7.7
Holdings directors		0.7		0.6
Total recognized by Holdings	$	8.5	$	8.3

Fair value of restricted stock that vested during the period:
CUSA employees	$	13.3	$	7.9
Holdings directors		1.4		1.3
Holdings total	$	14.7	$	9.2

Income tax benefit related to vested restricted stock:
CUSA employees	$	2.1	$	0.7
Holdings directors		0.3		0.3
Holdings total income tax benefit	$	2.4	$	1.0

As of June 30, 2024, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was as follows:


	Estimated
	Remaining
	Expense
CUSA employees (1)	$	23.2
Holdings directors		1.3
Total remaining - Holdings (1)	$	24.5

(1)

The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 1.7 years.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Performance Stock Units

During the six months ended June 30, 2024, Holdings granted performance awards to certain CUSA employees in the form of performance stock units (“PSU”). Each PSU that vests will result in the issuance of one share of Holdings’ common stock. The maximum number of shares issuable under the performance awards granted during 2024 is approximately 1.15 shares of Holdings' common stock. The grant date fair value for the units issued was determined based on the closing price of Holdings' common stock on the date of grant, which was $16.43 per share. The performance metrics for these performance awards are based upon three-year aggregate consolidated Adjusted EBITDA and consolidated cash flows, and payout levels are determined based upon the achievement of pre-established criteria for these metrics as defined in the award agreement. Based upon the terms of the award agreement, PSUs vest based on a combination of performance factors and continued service. The performance measurement period for the PSUs is the three-year period ended December 31, 2026 and the service period ends on February 19, 2027. Below is a summary of the performance metrics and measurement period for these performance awards:


Stock units that vest if performance metrics meet the target level		0.57 PSUs
Stock units that vest if performance metrics meet the threshold level (50% of target)		0.28 PSUs
Stock units that vest if performance metrics meet the maximum level (200% of target)		1.15 PSUs
Performance Measurement Period		Three years
Service Period		Third anniversary of grant date
Most likely performance metrics outcome estimated to be achieved at the time performance stock units were issued		Target
Assumed forfeiture rate for performance stock unit awards		5%

Below is a summary of all performance stock unit activity for the periods presented:


	Six Months Ended June 30,
	2024			2023
Number of performance stock units that vested during the period		0.1			0.1
Fair value of performance stock units that vested during the period	$	2.1		$	1.4
Accumulated dividends paid upon vesting of performance stock units	$	0.1		$	0.2
Compensation expense recognized during the period (1)	$	7.2		$	4.2
Income tax expense related to performance stock units	$	(0.7	)	$	(0.2	)

(1)

Compensation expense for the six months ended June 30, 2024 includes approximately $2.3 related to a change in the most likely performance metrics outcome estimated to be achieved for the 2023 and 2024 grants.

As of June 30, 2024, the estimated remaining unrecognized compensation expense related to outstanding performance stock units was $19.7. The weighted average period over which this remaining compensation expense will be recognized is approximately 1.6 years. As of June 30, 2024, Holdings had performance stock units outstanding that represented a total of approximately 2.6 hypothetical shares of common stock, net of estimated forfeitures, reflecting the actual certified performance level for performance stock units granted during 2022, an estimated performance level just below the maximum performance level for the 2023 grants and an estimated performance level slightly above the target performance level for the 2024 grants.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

11.

Goodwill and Other Intangible Assets

A summary of the Company's goodwill is as follows:


	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2024 (1)	$	1,182.9	$	68.1		$	1,251.0
Foreign currency translation adjustments		—		(7.1	)		(7.1	)
Balance at June 30, 2024 (1)	$	1,182.9	$	61.0		$	1,243.9

(1)

Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment. See discussion of the qualitative impairment analysis performed by the Company as of June 30, 2024 at Note 12.

A summary of the Company's intangible assets is as follows:


	Balance at January 1, 2024			Amortization			Foreign Currency Translation Adjustments			Balance at June 30, 2024
Intangible assets with finite lives:
Gross carrying amount	$	77.8		$	—		$	(0.1	)	$	77.7
Accumulated amortization		(75.3	)		(1.0	)		—			(76.3	)
Total net intangible assets with finite lives	$	2.5		$	(1.0	)	$	(0.1	)	$	1.4

Intangible assets with indefinite lives:
Tradename and other		300.3			—			(0.2	)		300.1
Total intangible assets, net	$	302.8		$	(1.0	)	$	(0.3	)	$	301.5

The estimated aggregate future amortization expense for intangible assets is as follows:


	Estimated
	Amortization
For the six months ended December 31, 2024	$	1.0
For the twelve months ended December 31, 2025		0.4
Total	$	1.4

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

12.

Impairment of Long-Lived Assets

The Company performed a qualitative impairment analysis on its long-lived assets, including theatre properties and right of-use assets, goodwill and tradename intangible assets as of June 30, 2024. As a result of the qualitative assessment, the Company noted no impairment indicators related to these assets as of June 30, 2024.

The qualitative impairment analysis, by asset class, is described below:

•

Theatre Properties and Right-of-Use-Assets - Considers relevant industry, economic and market conditions, industry trading multiples and recent developments that would impact the Company’s estimates of future theatre-level cash flows, which are the primary estimate of fair market value, at the theatre level compared with the most recent quantitative impairment assessment.

•

Goodwill – Considers economic and market conditions, industry trading multiples and the impact of recent developments that would impact the estimated fair values as determined in the most recent quantitative assessment.

•

Tradename Intangible Assets – Considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared with the most recent quantitative assessment.

See Note 1 and Note 12 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed February 16, 2024, for further discussion of the Company’s impairment policy and a description of the qualitative and quantitative impairment assessments performed.

There were no impairment charges recorded for long-lived assets, goodwill and intangible assets for the three and six months ended June 30, 2024. The following table summarizes the Company’s impairment charges for the three and six months ended June 30, 2023.



	Three Months Ended June 30,		Six Months Ended June 30,
	2023		2023
U.S. Segment
Theatre properties	$	3.9	$	3.9
Theatre operating lease right-of-use assets		3.4		3.4
Investment in NCMI/NCM		—		0.7
U.S. total		7.3		8.0

International segment
Theatre properties		0.6		0.6
Theatre operating lease right-of-use assets		1.5		1.5
International total		2.1		2.1

Total Impairment	$	9.4	$	10.1

13.

Fair Value Measurements

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Below is a summary of assets and liabilities measured at fair value on a recurring basis under FASB ASC Topic 820 as of June 30, 2024 and December 31, 2023:


		Carrying		Fair Value Hierarchy
Description	As of	Value		Level 1		Level 2		Level 3
Interest rate swap assets (1)	June 30, 2024	$	13.5	$	—	$	13.5	$	—
Investment in NCMI (2)	June 30, 2024	$	19.2	$	19.2	$	—	$	—

Interest rate swap assets (1)	December 31, 2023	$	9.9	$	—	$	9.9	$	—
Investment in NCMI (2)	December 31, 2023	$	18.1	$	—	$	18.1	$	—

(1)

See further discussion of interest rate swaps at Note 7.

(2)

See further discussion of investment in NCMI at Note 8.

See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed February 16, 2024. There were no changes in valuation techniques during the six months ended June 30, 2024. The Company’s investment in NCMI was transferred out of Level 2 into Level 1 during the first quarter of 2024.

14.

Foreign Currency Translation

The accumulated other comprehensive loss account in Holdings’ stockholders’ equity of $389.8 and $363.9 and CUSA’s stockholder's equity of $392.6 and $366.7, as of June 30, 2024 and December 31, 2023, respectively, primarily includes cumulative net foreign currency losses of $407.8 and $384.9 as of June 30, 2024 and December 31, 2023, respectively, from translating the financial statements of the Company's international subsidiaries and the cumulative changes in fair value of the interest rate swap agreements that are designated as hedges.

As of June 30, 2024, all foreign countries where the Company has operations are non-highly inflationary, other than Argentina. In non-highly inflationary countries, the local currency is the same as the functional currency and any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial information of the Company’s Argentina subsidiaries was remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective July 1, 2018.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside of Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. During the six months ended June 30, 2023, the Company entered into Blue Chip Swap transactions that resulted in a loss of approximately $4.9 which is reflected in “Foreign currency exchange and other related loss” in the Company’s consolidated statement of income for the six months ended June 30, 2023. The Company did not enter into any Blue Chip Swap transactions during the six months ended June 30, 2024.

Below is a summary of the impact of translating the June 30, 2024 and June 30, 2023 financial statements of the Company’s international subsidiaries:


					Other Comprehensive Income (Loss) for the
	Exchange Rate as of				Six Months Ended
Country	June 30, 2024		December 31, 2023		June 30, 2024			June 30, 2023
Brazil		5.60		4.85	$	(15.8	)	$	6.6
Chile		947.55		879.54		(5.7	)		4.1
All other						(1.4	)		1.5
					$	(22.9	)	$	12.2

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. For the six months ended June 30, 2024 and 2023 the Company recorded foreign currency exchange losses of $2.1 and $8.0 (excluding the impact of the Blue Chip Swap transactions noted above), respectively, due to the translation of Argentina's financial results to U.S. dollars.

15.

Supplemental Cash Flow Information

The following is provided as supplemental information to the condensed consolidated statements of cash flows:


	Six Months Ended
	June 30,
	2024			2023
Cash paid for interest by Holdings (1)	$	76.4		$	77.0
Cash paid for interest by CUSA	$	66.0		$	66.6
Cash paid for income taxes, net	$	12.8		$	7.2
Noncash operating activities:
Interest expense - NCM (see Note 8)	$	(11.1	)	$	(11.4	)
Noncash investing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (2)	$	0.5		$	1.5
Theatre and other assets acquired under finance leases	$	28.0		$	—
Investment in NCMI – receipt of common units in NCM (see Note 8)	$	0.5		$	—

(1)

Includes the cash interest paid by CUSA.

(2)

Additions to theatre properties and equipment included in accounts payable as of June 30, 2024 and December 31, 2023 were $7.1 and $6.6, respectively.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

16.

Segments - Holdings

The international market and U.S. market are managed as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. The Company closed its one theatre in Curacao in January 2023 and sold the shares of its Ecuador subsidiary in September 2023. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenue. Holdings uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of, or allocate resources between, segments.

Below is a breakdown of selected financial information by reportable operating segment for Holdings:


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023
Revenue
U.S.	$	575.1		$	739.3		$	1,034.2		$	1,221.0
International		162.2			207.4			284.4			339.0
Eliminations		(3.1	)		(4.4	)		(5.2	)		(7.0	)
Total revenue	$	734.2		$	942.3		$	1,313.4		$	1,553.0

Adjusted EBITDA
U.S.	$	108.8		$	180.8		$	157.9		$	244.2
International		33.3			50.7			54.9			73.5
Total Adjusted EBITDA	$	142.1		$	231.5		$	212.8		$	317.7

Capital expenditures
U.S.	$	16.1		$	21.1		$	34.2		$	43.8
International		7.6			7.2			13.0			10.8
Total capital expenditures	$	23.7		$	28.3		$	47.2		$	54.6

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

The following table sets forth a reconciliation of net income to Adjusted EBITDA for Holdings:


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023
Net income	$	46.6		$	120.4		$	71.9		$	117.9
Add (deduct):
Income tax (benefit) expense		(0.9	)		12.3			(28.6	)		8.4
Interest expense (1)		34.6			37.1			72.3			73.9
Other loss (income), net (2)		0.1			(12.1	)		(17.6	)		(14.0	)
Cash distributions from equity investees (3)		1.6			1.6			2.9			1.6
Depreciation and amortization		49.8			52.8			99.2			107.7
Impairment of long-lived and other assets		—			9.4			—			10.1
Loss (gain) on disposal of assets and other		1.7			(3.0	)		2.1			(2.7	)
Loss on debt amendments and extinguishments		2.5			10.7			2.5			10.7
Non-cash rent expense		(3.2	)		(4.5	)		(7.6	)		(8.4	)
Share-based awards compensation expense		9.3			6.8			15.7			12.5
Adjusted EBITDA	$	142.1		$	231.5		$	212.8		$	317.7

(1)

Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated gains for amended swap agreements.

(2)

Includes interest income, foreign currency exchange and other related loss, interest expense - NCM, equity in income (loss) of affiliates and net gain (loss) on investment in NCMI.

(3)

Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. These distributions are reported entirely within the U.S. operating segment.

Financial Information About Geographic Areas

Below is a breakdown of selected financial information for Holdings by geographic area:


	Three Months Ended						Six Months Ended
	June 30,						June 30,
Revenue	2024			2023			2024			2023
U.S.	$	575.1		$	739.3		$	1,034.2		$	1,221.0
Brazil		58.6			68.7			112.9			113.2
Other international countries		103.6			138.7			171.5			225.8
Eliminations		(3.1	)		(4.4	)		(5.2	)		(7.0	)
Total	$	734.2		$	942.3		$	1,313.4		$	1,553.0


	As of		As of
Theatre properties and equipment, net	June 30, 2024		December 31, 2023
U.S.	$	981.7	$	1,002.1
Brazil		45.0		54.7
Other international countries		99.1		104.9
Total	$	1,125.8	$	1,161.7

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

17.

Related Party Transactions

A subsidiary of the Company manages a theatre for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, who is Lee Roy Mitchell’s son-in-law and Kevin Mitchell’s brother-in-law. Lee Roy Mitchell, our founder, owns, both directly and indirectly, approximately 8.5% of Holdings’ common stock and Kevin Mitchell is a member of Holdings’ Board of Directors. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenue. The Company recorded $0.3 and $0.4 of management fee revenue during the six months ended June 30, 2024 and 2023, respectively. All such amounts are included in the condensed consolidated statements of income, with the intercompany amounts eliminated in consolidation. During the six months ended June 30, 2024 and 2023, the Company paid excess cash distributions of $0.3 and $0.3, respectively to Lone Star Theatres, Inc. as required by the partnership agreement, which were recorded as a reduction of noncontrolling interests on each of Holdings and CUSA’s condensed consolidated balance sheets.

A subsidiary of the Company leases 12 theatres from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Holdings' directors and is an officer of the general partner of Syufy. For the six months ended June 30, 2024 and 2023, the Company paid total rent of $11.4 and $10.9, respectively, to Syufy. CUSA provides digital equipment support to drive-in theatres owned by Syufy. The Company recorded management fees related to these services of $0.03 and $0.03 during the six months ended June 30, 2024 and 2023, respectively.

A subsidiary of the Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity which owns the remaining 50% of FE Concepts. AWSR is owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. CUSA has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded management fees of $0.03 and $0.03 related to these services during the six months ended June 30, 2024 and 2023, respectively.

18.

Commitments and Contingencies

From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company. The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the closure of the Company’s theatres due to the COVID-19 pandemic. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. The Company cannot predict the outcome of this litigation. The District Court granted FM’s motion for summary judgment. The Company has appealed the District Court’s decision.

Gerardo Rodriguez, individually and on behalf of a class of all others similarly situated vs Cinemark USA, Inc. and Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on February 24, 2023 in the Cook County Circuit Court in Illinois alleging violation of the Fair and Accurate Credit Transactions Act. The Company firmly maintains that the allegations are without merit and will vigorously defend itself against the lawsuit. The Company cannot predict the outcome of this litigation.

National CineMedia LLC Bankruptcy. On June 3, 2023, NCM filed an Emergency Motion for Entry of an Order (1) approving and Authorizing Debtor to Enter into and Perform Under (a) the Termination and Settlement Agreement and (b) the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. (the “9019 Motion”). The 9019 Motion requested an order, among other things, that the most favored nations clause (the “MFN”) in Cinemark’s Exhibitor Services Agreement was not triggered by the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. On June 14, 2023, Cinemark filed an objection to the 9019 Motion. On June 26, 2023, the bankruptcy court entered a confirmation order, which among other things, approves NCM’s assumption of Cinemark’s Exhibitor Services Agreement but fails to preserve or recognize Cinemark’s rights under the MFN with respect to the Network Affiliate Transaction Agreement. Cinemark has appealed the confirmation order in the United States District Court for the Southern District of Texas, Houston Division. The Company cannot predict the outcome of this appeal.

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data, unaudited)

Shane Waldrop, individually and on behalf of all other similarly situated, vs. Cinemark USA, Inc. This putative nationwide class action lawsuit was filed against the Company on April 16, 2024, in the United States District Court for the Eastern District of Texas, Sherman Division, alleging violations of the Federal Food Drug & Cosmetics Act, violations of the Texas Deceptive Trade Practices Act, negligent misrepresentation, fraud and unjust enrichment based on the Company’s alleged mislabeling of twenty-four ounce draft beer cups used at certain theatres. The Company denies the allegations and will vigorously defend itself against the lawsuit. The Company cannot predict the outcome of this litigation.

19. Income Taxes

An income tax benefit of $28.6 for Holdings and $27.9 for CUSA was recorded during the six months ended June 30, 2024 resulting in an effective tax rate of approximately (66.0)% for Holdings and (55.0)% for CUSA, respectively.

During the six months ended June 30, 2024, the Company recorded a deferred tax benefit of $39.5 discretely related to the release of valuation allowances in certain foreign jurisdictions. The release of these valuation allowances was the result of the availability of positive evidence related to sustained taxable income in the relevant jurisdictions to support the future realizability of deferred tax assets. This discrete benefit favorably impacted the effective tax rates of Holdings and CUSA for the six months ended June 30, 2024, causing the income tax benefit to vary significantly from the tax expense derived by applying the statutory tax rate to the pre-tax income of Holdings and CUSA.

There is a possibility that within the next 12 months, sufficient positive evidence may become available to reach a conclusion that a portion of the valuation allowance in the U.S. will no longer be required.

20. Subsequent Events

On July 18, 2024, CUSA issued $500.0 7.00% senior notes, at par (the “7.00% Senior Notes”). The notes will mature on August 1, 2032. Interest on the 7.00% Senior Notes will be payable on February 1 and August 1 of each year, beginning on February 1, 2025. CUSA incurred debt issuance costs of approximately $7.0 in connection with the issuance, which will be recorded as a reduction of long-term debt on the Company’s consolidated balance sheet. Proceeds, after payment of fees, will be used to repurchase any of CUSA’s 5.875% $405.0 aggregate principal amount of Senior Notes due March 2026 (the “5.875% Senior Notes”), tendered as discussed below, and for general corporate purposes.

Concurrently with the 7.00% Senior Notes bond offering, on July 9, 2024, CUSA commenced a cash tender offer to purchase any and all of CUSA’s 5.875% Senior Notes. On July 18, 2024, CUSA completed the tender offer to repurchase any and all of its 5.875% Senior Notes, of which $345.3 was tendered at the expiration of the tender offer. Accordingly, $59.7 aggregate principal amount of the 5.875% Senior Notes remains outstanding.

The notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries, or its guarantors, that guarantee, assume or in any other manner become liable with respect to any of CUSA’s or its guarantors’ other debt. The 7.00% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of CUSA’s and its guarantor’s existing and future senior debt, including the 5.25% senior notes due 2028, the 5.875% senior notes due 2026 that remain outstanding following the tender offer to redeem the 5.875% Senior Notes, and all borrowings under CUSA’s Credit Agreement. The notes and the guarantees will be structurally subordinated to all existing and future debt and other liabilities of CUSA’s non-guarantor subsidiaries. The notes and the guarantees will be structurally senior to the 4.50% convertible senior notes due 2025, and all future debt, if any, issued by Holdings that is not guaranteed by CUSA or any of its subsidiaries.

CUSA may redeem the 7.00% Senior Notes in whole or in part at redemption prices set forth in the indenture. Prior to August 1, 2027, CUSA has the option to redeem all or a portion of the 7.00% Senior Notes at a price equal to 100.0% of the principal amount thereof, plus accrued and unpaid interest, if any, plus a make-whole premium. On or after August 1, 2027, CUSA may redeem the 7.00% Senior Notes in whole or in part at redemption prices specified in the indenture. Prior to August 1, 2027, CUSA may redeem up to 40% of the aggregate principal amount of the 7.00% Senior Notes with funds in an amount equal to the net proceeds of certain equity offerings at 107.0% of the principal amount.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes and schedules included elsewhere in this report. Amounts included in the following discussion, except for theatres, screens, average screens, average ticket price and concessions revenue per patron, are rounded in millions.

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. As of June 30, 2024, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 16 to the condensed consolidated financial statements.

The success of the theatrical exhibition industry is contingent upon several key factors, including the volume of new film content available, which has been impacted by the effects of the COVID-19 pandemic and last year’s writers’ and actors’ guilds strikes (the “Hollywood strikes”), the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment.

Revenue and Expense

We generate revenue primarily from filmed entertainment box office receipts and concession sales with additional revenue from screen advertising, screen rental and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of our theatres. Filmed entertainment box office receipts include traditional content from studios as well as alternative entertainment, such as the Metropolitan Opera, concert events, live and pre-recorded sports programs and other special events in our theatres. NCM provides our domestic theatres with various forms of in-theatre advertising. Our Flix Media subsidiaries provide screen advertising and alternative content for our international circuit and for other international exhibitors.

Films leading the box office during the six months ended June 30, 2024 included Inside Out 2, Dune: Part Two, Godzilla x Kong: The New Empire, Kung Fu Panda 4, Kingdom of the Planet of the Apes, Bad Boys: Ride or Die, Ghostbusters: Frozen Empire, IF, Bob Marley: One Love, and The Fall Guy.

Film rental costs are variable in nature and fluctuate with our admissions revenue. Film rental costs as a percentage of revenue are generally higher for periods in which more blockbuster films are released. Advertising costs, which are expensed as incurred, are primarily related to expanding our customer base, increasing the frequency of visits and growing loyalty. These expenses vary depending on the timing and length of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenue and also product mix. Inflationary pressures have impacted, and may continue to impact, product costs in the near term. We source products from a variety of partners around the world to minimize supply chain interruptions and price increases, wherever possible.

Although salaries and wages include a fixed cost component (i.e., the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages tend to move in relation to anticipated changes in attendance. Staffing levels may vary based on the amenities offered at each location, such as full-service restaurants, bars or expanded food and beverage options. In certain international locations, staffing levels are also subject to local regulations, including minimum hour requirements. Inflationary pressures have driven increases in wage rates across our labor base and increases may continue in the future.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenue is also affected by the number of theatres under operating leases, the number of theatres under finance leases and the number of owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, property taxes, janitorial costs, credit card fees, third party ticket sales commissions, gift card commissions, repairs and maintenance expenses, security services, and projection and sound equipment maintenance expenses.

General and administrative expenses to support the overall management of the Company are primarily fixed in nature. Fixed expenses include salaries, wages and benefits costs for our corporate office personnel, facility expenses for our corporate and other offices, software license and maintenance costs and audit fees. General and administrative expenses also include some variable expenses such as incentive compensation, consulting and legal fees, supplies, and other costs that are not specifically associated with the operations of our theatres.

Recent Developments

On July 18, 2024, CUSA issued $500.0 million 7.00% senior notes, at par (the “7.00% Senior Notes”). The notes will mature on August 1, 2032. Interest on the 7.00% Senior Notes will be payable on February 1 and August 1 of each year, beginning on February 1, 2025. CUSA incurred debt issuance costs of approximately $7.0 million in connection with the issuance, which will be recorded as a reduction of long-term debt on the Company’s consolidated balance sheet. Proceeds, after payment of fees, will be used to repurchase any of CUSA’s 5.875% $405.0 million aggregate principal amount of Senior Notes due March 2026 (the “5.875% Senior Notes”), tendered as discussed below, and for general corporate purposes.

Concurrently with the 7.00% Senior Notes bond offering, on July 9, 2024, CUSA commenced a cash tender offer to purchase any and all of CUSA’s 5.875% Senior Notes. On July 18, 2024, CUSA completed the tender offer to purchase any and all of its 5.875% Senior Notes, of which $345.3 million was tendered at the expiration of the tender offer. Accordingly, $59.7 million aggregate principal amount of the 5.875% Senior Notes remains outstanding.

Results of Operations

The following table sets forth, for the periods indicated, the amounts for certain items reflected in the operating income of Holdings along with each of those items as a percentage of revenue.


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2024			2023			2024			2023
Operating data (in millions):
Revenue
Admissions	$	365.8		$	478.4		$	655.6		$	789.4
Concession		292.9			373.4			517.1			609.2
Other		75.5			90.5			140.7			154.4
Total revenue	$	734.2		$	942.3		$	1,313.4		$	1,553.0
Cost of operations
Film rentals and advertising		204.0			278.0			358.3			444.7
Concession supplies		56.6			67.4			100.6			111.0
Salaries and wages		97.3			112.1			184.2			198.3
Facility lease expense		81.5			87.0			158.8			166.5
Utilities and other		104.7			120.2			205.1			224.0
General and administrative expenses (1)		55.7			50.0			104.6			96.5
Depreciation and amortization		49.8			52.8			99.2			107.7
Impairment of long-lived and other assets		—			9.4			—			10.1
Loss (gain) on disposal of assets and other		1.7			(3.0	)		2.1			(2.7	)
Total cost of operations (1)		651.3			773.9			1,212.9			1,356.1
Operating income (1)	$	82.9		$	168.4		$	100.5		$	196.9

Operating data as a percentage of total revenue:
Revenue
Admissions		49.8	%		50.8	%		49.9	%		50.8	%
Concession		39.9	%		39.6	%		39.4	%		39.2	%
Other		10.3	%		9.6	%		10.7	%		10.0	%
Total revenue		100.0	%		100.0	%		100.0	%		100.0	%
Cost of operations (2)
Film rentals and advertising		55.8	%		58.1	%		54.7	%		56.3	%
Concession supplies		19.3	%		18.1	%		19.5	%		18.2	%
Salaries and wages		13.3	%		11.9	%		14.0	%		12.8	%
Facility lease expense		11.1	%		9.2	%		12.1	%		10.7	%
Utilities and other		14.3	%		12.8	%		15.6	%		14.4	%
General and administrative expenses		7.6	%		5.3	%		8.0	%		6.2	%
Depreciation and amortization		6.8	%		5.6	%		7.6	%		6.9	%
Impairment of long-lived and other assets		—	%		1.0	%		—	%		0.7	%
Loss (gain) on disposal of assets and other		0.2	%		(0.3	)%		0.2	%		(0.2	)%
Total cost of operations		88.7	%		82.1	%		92.3	%		87.3	%
Operating income		11.3	%		17.9	%		7.7	%		12.7	%
Average screen count (3)		5,708			5,828			5,710			5,832

(1)

The only difference between components of operating income for Holdings, as presented above, and those of CUSA is incremental general and administrative expense recognized by Holdings. The following table sets forth, for the periods indicated, the amounts for general and administrative expense, total cost of operations and operating income of CUSA:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Operating data (in millions):
Cost of operations
General and administrative expenses	$	54.7	$	49.1	$	102.7	$	94.7
Total cost of operations	$	650.3	$	773.0	$	1,211.0	$	1,354.3
Operating income	$	83.9	$	169.3	$	102.4	$	198.7

(2)

All costs are expressed as a percentage of total revenue, except film rentals and advertising, which are expressed as a percentage of admissions revenue, and concession supplies, which are expressed as a percentage of concession revenue.

(3)

Average screen count is calculated based on the average of month end screen counts.

Three months ended June 30, 2024 (the “second quarter of 2024”) versus the three months ended June 30, 2023 (the “second quarter of 2023”)

Second quarter of 2024 - The North American Industry box office generated approximately $2.0 billion during the second quarter of 2024, which included Inside Out 2, Kingdom of the Planet of the Apes, Bad Boys: Ride or Die, Godzilla x Kong: The New Empire, IF and The Fall Guy.

Second quarter of 2023 - The North American Industry box office was approximately $2.7 billion during the second quarter of 2023, which included The Super Mario Bros. Movie, Guardians of the Galaxy Vol. 3, Spider-Man: Across the Spider-Verse, The Little Mermaid, Fast X and Transformers: Rise of the Beasts.

Revenue. The table below, presented by reportable operating segment, summarizes our year-over-year revenue performance and certain key performance indicators that impact our revenue.


	U.S. Operating Segment				International Operating Segment						Consolidated
	Three Months Ended June 30,				Three Months Ended June 30,						Three Months Ended June 30,
	2024		2023		2024		2023		Constant Currency (3) 2024		2024		2023
Admissions revenue	$	287.4	$	373.4	$	78.4	$	105.0	$	123.8	$	365.8	$	478.4
Concession revenue		231.4		296.3		61.5		77.1		95.2		292.9		373.4
Other revenue (1)		53.2		65.2		22.3		25.3		34.4		75.5		90.5
Total revenue (1)	$	572.0	$	734.9	$	162.2	$	207.4	$	253.4	$	734.2	$	942.3
Attendance		29.1		38.8		20.9		25.6				50.0		64.4
Average ticket price (2)	$	9.88	$	9.62	$	3.75	$	4.10	$	5.92	$	7.32	$	7.43
Concession revenue per patron (2)	$	7.95	$	7.64	$	2.94	$	3.01	$	4.56	$	5.86	$	5.80

(1)

U.S. operating segment revenue includes eliminations of intercompany transactions with the international operating segment. See Note 16 to our condensed consolidated financial statements.

(2)

Average ticket price is calculated as admissions revenue divided by attendance. Concession revenue per patron is calculated as concession revenue divided by attendance.

(3)

Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2023. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

•

U.S. Attendance decreased 25.0% to 29.1 million patrons during the second quarter of 2024 compared with 38.8 million patrons during the second quarter of 2023 driven by the lower concentration of high-grossing titles and overall mix of film releases due to the impact of the Hollywood strikes. Average ticket price increased 2.7% to $9.88 during the second quarter of 2024 compared with $9.62 during the second quarter of 2023 primarily driven by strategic pricing actions. Concession revenue per patron increased 4.1% to $7.95 during the second quarter of 2024 compared with $7.64 during the second quarter of 2023 primarily driven by inflationary and strategic pricing actions. Other revenue for the second quarter of 2024 decreased 18.4% to $53.2 million compared with $65.2 million during the second quarter of 2023 primarily due to a decrease in attendance, which resulted in a reduction in the variable component of other revenue.

•

International. Attendance decreased 18.4% to 20.9 million patrons during the second quarter of 2024 compared with 25.6 million patrons during the second quarter of 2023 driven by the lower concentration of high-grossing titles and reduced scale of film releases due to the impact of the Hollywood strikes. Revenues, average ticket price and concession revenue per patron for our international segment, as reported, were unfavorably impacted by exchange rate fluctuations for the second quarter of 2024. In constant currency, the average ticket price increased 44.4% to $5.92 for the second quarter of 2024 primarily due to inflationary pricing actions, partially offset by promotional activity. Similarly, in constant currency, concession revenue per patron increased 51.5% to $4.56 for the second quarter of 2024 primarily due to inflationary pricing actions. Other revenue increased 36.0% in constant currency to $34.4 million for the second quarter of 2024 primarily due to higher loyalty program and screen advertising revenue driven by inflation.

Cost of Operations. The table below, presented by reportable operating segment, summarizes our year-over-year theatre operating costs.


	U.S. Operating Segment				International Operating Segment						Consolidated
	Three Months Ended June 30,				Three Months Ended June 30,						Three Months Ended June 30,
	2024		2023		2024		2023		Constant Currency (1) 2024		2024		2023
Film rentals and advertising	$	164.6	$	224.0	$	39.4	$	54.0	$	63.2	$	204.0	$	278.0
Concession supplies	$	43.2	$	50.4	$	13.4	$	17.0	$	20.7	$	56.6	$	67.4
Salaries and wages	$	80.8	$	92.5	$	16.5	$	19.6	$	27.9	$	97.3	$	112.1
Facility lease expense	$	60.0	$	61.9	$	21.5	$	25.1	$	29.2	$	81.5	$	87.0
Utilities and other	$	80.1	$	90.3	$	24.6	$	29.9	$	40.5	$	104.7	$	120.2

(1)

Constant currency expense amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2023. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

•

U.S. Film rentals and advertising costs for the second quarter of 2024 were 57.3% of admissions revenue compared with 60.0% for the second quarter of 2023 due to the concentration of box office and mix of films. Concession supplies expense for the second quarter of 2024 was 18.7% of concession revenue compared with 17.0% of concession revenue for the second quarter of 2023. The concession supplies rate for the second quarter of 2024 was impacted by inflationary pressures on certain concession categories and higher shrink, partially offset by the impact of strategic pricing actions on concession revenue,

Salaries and wages decreased 12.6% to $80.8 million for the second quarter of 2024 compared with $92.5 million for the second quarter of 2023 due to lower attendance, labor productivity initiatives and reduced operating hours, partially offset by higher wage rates. Facility lease expense, which is predominantly fixed in nature, decreased 3.1% to $60.0 million primarily due to theatre closures and lease renegotiations. Utilities and other costs decreased 11.3% to $80.1 million, as many of these costs are variable or semi-variable in nature and were impacted by the decrease in attendance. A decrease in property taxes also contributed to the decline in utilities and other costs.

•

International. Our international operating costs, as reported, were favorably impacted by exchange rate fluctuations for the second quarter of 2024.

Film rentals and advertising costs were 50.3% of admissions revenue as reported for the second quarter of 2024 compared with 51.4% for the second quarter of 2023 driven by the concentration of box office and the mix of films. Concession supplies expense was 21.8% of concessions revenue as reported for the second quarter of 2024 compared with 22.0% of concession revenue for the second quarter of 2023. The decrease in the concession supplies rate was primarily driven by the impact of inflationary pricing actions on concession revenue, as well as product mix.

Salaries and wages, facility lease expense and utilities and other expenses, as reported, were lower for the second quarter of 2024 as a result of favorable exchange rate fluctuations. In constant currency, salaries and wages increased to $27.9 million for the second quarter of 2024 primarily due to wage rate inflation, partially offset by labor productivity initiatives and lower attendance. Facility lease expense increased to $29.2 million in constant currency for the second quarter of 2024 driven by inflationary increases and the return of certain minimum rent thresholds, partially offset by lower percentage rent. Utilities and other costs increased to $40.5 million in constant currency for the second quarter of 2024 primarily due to inflationary pressures and higher utility costs.

General and Administrative Expense. General and administrative expense for Holdings increased to $55.7 million for the second quarter of 2024 compared with $50.0 million for the second quarter of 2023. General and administrative expense for CUSA increased to $54.7 million for the second quarter of 2024 compared with $49.1 million for the second quarter of 2023. The increase for both Holdings and CUSA is primarily due to wages and benefits inflation, as well as higher share-based compensation and related payroll taxes, partially offset by the favorable impact of exchange rate fluctuations.

Depreciation and Amortization. Depreciation and amortization expense decreased to $49.8 million for the second quarter of 2024 compared with $52.8 million for the second quarter of 2023 due in part to the impairment of assets during 2023 and the favorable impact of exchange rate fluctuations.

Loss (Gain) on Disposal of Assets and Other. A loss on disposal of assets and other of $1.7 million was recorded for the second quarter of 2024 compared with a gain of $3.0 million for the second quarter of 2023. Activity for the second quarter of 2024 was primarily related to the removal and disposal of equipment at closed theatres. Activity for the second quarter of 2023 was primarily related to the write-off of operating lease obligations for theatres that were closed during the second quarter of 2023.

million during the second quarter of 2023. The interest expense attributable to CUSA, which includes amortization of debt issuance costs and original issue discount and amortization of accumulated losses for swap amendments, was $28.6 million during the second quarter of 2024 compared with $31.0 million during the second quarter of 2023. The decrease in interest expense was primarily due to the redemption of our 8.75% Secured Notes, partially offset by a higher average interest rate on our term loan borrowings. See further discussion at Liquidity and Capital Resources below.

Interest Income. Interest income for Holdings was $12.5 million during the 2024 period compared with $13.0 million during the 2023 period. The interest income attributable to CUSA was $9.4 million during the 2024 period compared with $10.1 million during the 2023 period. The decrease in interest income primarily reflects lower average cash and cash equivalents balances, partially offset by higher interest rates earned on those balances.

Loss on Debt Amendments and Extinguishments. We recorded a loss on amendment and extinguishment of debt of $2.5 million during the second quarter of 2024 related to the amendment of our term loan and the redemption of the remaining 8.75% Secured Notes, including the write-off of unamortized debt issuance costs and original issue discount, and legal and other fees paid. We recorded a loss on amendment and extinguishment of debt of $10.7 million during the second quarter of 2023 related to the amendment of our Senior Secured Credit Facilities and the partial redemption of the 8.75% Secured Notes, including the write-off of unamortized debt issuance costs and legal and other fees paid. See Note 7 to the condensed consolidated financial statements for information about our loss on debt amendments and extinguishments.

Foreign Currency Exchange and Other Related Loss. We recorded a foreign currency exchange loss of $6.3 million during the second quarter of 2024 compared with a loss of $6.2 million during the second quarter of 2023. Activity for the second quarter of 2023 includes a $4.9 million loss associated with Blue Chip Swap transactions. Excluding the impact of the Blue Chip Swap transactions, the gain or loss on foreign exchange is primarily related to currency exchange fluctuations from original transactions dates until settlement. See Note 14 to the condensed consolidated financial statements for a discussion of Blue Chip Swap transactions.

Equity in Income of Affiliates. Equity in income of affiliates of $2.5 million was recorded during the second quarter of 2024 compared with equity in income of affiliates of $1.8 million during the second quarter of 2023. See Note 9 to the condensed consolidated financial statements for information about our equity investments.

Net (Loss) Gain on Investment in NCMI. We recorded a net loss on our investment in NCMI of $3.2 million during the second quarter of 2024 compared with a gain of $9.2 million during the second quarter of 2023, primarily related to the mark-to-market adjustment of our investment in NCMI under the fair value basis of accounting. See Note 8 to the condensed consolidated financial statements for information about our investment in NCMI.

Income Taxes - Holdings. An income tax benefit of $0.9 million was recorded for the second quarter of 2024 compared with income tax expense of $12.3 million for the second quarter of 2023. The effective tax rate was approximately (1.8)% for the second quarter of 2024 compared with 9.3% for the second quarter of 2023. The effective tax rate for the second quarter of 2024 was favorably impacted by changes in valuation allowances previously recorded against certain deferred tax assets in certain foreign jurisdictions. The effective tax rate for the second quarter of 2023 was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in various jurisdictions. Income tax provisions for interim periods are generally based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Income Taxes - CUSA. An income tax benefit of $1.3 million was recorded for the second quarter of 2024 compared with income tax expense of $15.3 million for the second quarter of 2023. The effective tax rate was approximately (2.8)% for the second quarter of 2024 compared with 11.2% for the second quarter of 2023. The effective tax rate for the second quarter of 2024 was favorably impacted by changes in valuation allowances previously recorded against certain deferred tax assets in certatin foreign jurisdictions. The effective tax rate for the second quarter of 2023 was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in various jurisdictions. Income tax provisions for interim periods are generally based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Six months ended June 30, 2024 (the “2024 period”) versus the six months ended June 30, 2023 (the “2023 period”)

2024 Period - The North American Industry box office generated approximately $3.7 billion during the 2024 period, which included Inside Out 2, Dune: Part Two, Godzilla x Kong: The New Empire, Kung Fu Panda 4, Kingdom of the Planet of the Apes, Bad Boys: Ride or Die, Ghostbusters: Frozen Empire, IF, Bob Marley: One Love and The Fall Guy.

2023 Period - The North American Industry box office was approximately $4.5 billion during the 2023 period, which included the carryover of Avatar: The Way of Water and Puss in Boots: The Last Wish as well as new releases including The Super Mario Bros. Movie, Guardians of the Galaxy Vol. 3, Spider-Man: Across the Spider-Verse, The Little Mermaid, Ant-Man and the Wasp: Quantumania, John Wick: Chapter 4, Creed III, Fast X, Transformers: Rise of the Beasts and Indiana Jones and the Dial of Destiny.

Revenue. The table below, presented by reportable operating segment, summarizes our year-over-year revenue performance and certain key performance indicators that impact our revenue.


	U.S. Operating Segment				International Operating Segment						Consolidated
	Six Months Ended June 30,				Six Months Ended June 30,						Six Months Ended June 30,
	2024		2023		2024		2023		Constant Currency (3) 2024		2024		2023
Admissions revenue	$	519.2	$	618.1	$	136.4	$	171.3	$	209.1	$	655.6	$	789.4
Concession revenue		410.0		483.1		107.1		126.1		162.2		517.1		609.2
Other revenue (1)		99.8		112.8		40.9		41.6		61.7		140.7		154.4
Total revenue (1)	$	1,029.0	$	1,214.0	$	284.4	$	339.0	$	433.0	$	1,313.4	$	1,553.0
Attendance		52.7		64.0		37.0		43.3				89.7		107.3
Average ticket price (2)	$	9.85	$	9.66	$	3.69	$	3.96	$	5.65	$	7.31	$	7.36
Concession revenue per patron (2)	$	7.78	$	7.55	$	2.89	$	2.91	$	4.38	$	5.76	$	5.68

(1)

U.S. operating segment revenue includes eliminations of intercompany transactions with the international operating segment. See Note 16 to our condensed consolidated financial statements.

(2)

Average ticket price is calculated as admissions revenue divided by attendance. Concession revenue per patron is calculated as concession revenue divided by attendance.

(3)

•

U.S. Attendance decreased 17.7% to 52.7 million patrons during the 2024 period compared with 64.0 million patrons during the 2023 period driven by less carryover benefit in the 2024 period from prior year releases and the lower concentration of high-grossing titles and overall mix of film releases due to the impact of the Hollywood strikes. Average ticket price increased 2.0% to $9.85 during the 2024 period compared with $9.66 during the 2023 period driven by strategic pricing actions partially offset by lower 3D penetration in the 2024 period. Concession revenue per patron increased 3.0% to $7.78 during the 2024 period compared with $7.55 during the 2023 period primarily driven by inflationary and strategic pricing actions as well as product mix, partially offset by lower incidence rates associated with film content mix. Other revenue for the 2024 period decreased 11.5% to $99.8 million compared with $112.8 million during the 2023 period primarily due to a decrease in attendance, which resulted in a reduction in the variable component of other revenue.

•

International. Attendance decreased 14.5% to 37.0 million patrons during the 2024 period compared with 43.3 million patrons during the 2023 period due to less carryover benefit in the 2024 period from prior year releases and the lower concentration of high-grossing titles and reduced scale of film releases due to the impact of the Hollywood strikes. Revenues, average ticket price and concession revenue per patron for our international segment, as reported, were unfavorably impacted by exchange rate fluctuations for the 2024 period. In constant currency, the average ticket price increased 42.7% to $5.65 for the 2024 period primarily due to inflationary pricing actions. Similarly, in constant currency, concession revenue per patron increased 50.5% to $4.38 for the 2024 period primarily due to inflationary pricing actions. Other revenue increased 48.3% in constant currency to $61.7 million for the 2024 period primarily due to higher loyalty program and screen advertising revenue driven by inflation.

Cost of Operations. The table below, presented by reportable operating segment, summarizes our year-over-year theatre operating costs.


	U.S. Operating Segment				International Operating Segment						Consolidated
	Six Months Ended June 30,				Six Months Ended June 30,						Six Months Ended June 30,
	2024		2023		2024		2023		Constant Currency (1) 2024		2024		2023
Film rentals and advertising	$	290.9	$	357.5	$	67.4	$	87.2	$	105.3	$	358.3	$	444.7
Concession supplies	$	77.5	$	83.3	$	23.1	$	27.7	$	34.8	$	100.6	$	111.0
Salaries and wages	$	153.3	$	164.0	$	30.9	$	34.3	$	51.0	$	184.2	$	198.3
Facility lease expense	$	120.5	$	123.9	$	38.3	$	42.6	$	50.4	$	158.8	$	166.5
Utilities and other	$	158.4	$	170.8	$	46.7	$	53.2	$	74.3	$	205.1	$	224.0

(1)

•

U.S. Film rentals and advertising costs for the 2024 period were 56.0% of admissions revenue compared with 57.8% for the 2023 period due to the concentration of box office and mix of films. Concession supplies expense for the 2024 period was 18.9% of concession revenue compared with 17.2% of concession revenue for the 2023 period. The concession supplies rate for the 2024 period was impacted by inflationary pressures on certain concession categories, product mix and higher shrink, partially offset by the impact of strategic pricing actions.

Salaries and wages decreased 6.5% to $153.3 million for the 2024 period compared with $164.0 million for the 2023 period due to lower attendance and labor productivity initiatives, partially offset by higher wage rates. Facility lease expense, which is predominantly fixed in nature, decreased 2.7% to $120.5 million primarily due to theatre closures and lease renegotiations. Utilities and other costs decreased 7.3% to $158.4 million, as many of these costs are variable or semi-variable in nature and were impacted by the decrease in attendance. A decrease in property taxes also contributed to the decline in utilities and other costs.

•

International. Our international operating costs, as reported, were favorably impacted by exchange rate fluctuations for the 2024 period.

Film rentals and advertising costs were 49.4% of admissions revenue as reported for the 2024 period compared with 50.9% for the 2023 period due to the concentration of box office and mix of films. Concession supplies expense was 21.6% of concessions revenue as reported for the 2024 period compared with 22.0% of concession revenue for the 2023 period. The decrease in the concession supplies rate was primarily driven by the impact of strategic pricing actions to offset inflationary pressures.

Salaries and wages, facility lease expense and utilities and other expenses, as reported, were lower for the 2024 period as a result of favorable exchange rate fluctuations. In constant currency, salaries and wages increased to $51.0 million for the 2024 period primarily driven by wage rate inflation, partially offset by labor productivity initiatives and lower attendance. Facility lease expense increased to $50.4 million in constant currency for the 2024 period primarily due to inflationary increases and the return of certain minimum rent thresholds, partially offset by lower percentage rent. Utilities and other costs increased to $74.3 million in constant currency for the 2024 period due to inflationary pressures and higher utility costs.

General and Administrative Expense. General and administrative expense for Holdings increased to $104.6 million for the 2024 period compared with $96.5 million for the 2023 period. General and administrative expense for CUSA increased to $102.7 million for the 2024 period compared with $94.7 million for the 2023 period. The increase for both Holdings and CUSA is primarily due to wages and benefits inflation, as well as higher share-based compensation and related payroll taxes, partially offset by lower professional fees and the favorable impact of exchange rate fluctuations.

Depreciation and Amortization. Depreciation and amortization expense decreased to $99.2 million for the 2024 period compared with $107.7 million for the 2023 period due in part to the impairment of assets during 2023 and the favorable impact of exchange rate fluctuations.

Loss (Gain) on Disposal of Assets and Other. A loss on disposal of assets and other of $2.1 million was recorded for the 2024 period compared with a gain of $2.7 million for the 2023 period. Activity for the 2024 period was primarily related to the removal and disposal of equipment at closed theatres. Activity for the 2023 period was primarily related to the write-off of operating lease obligations for theatres that were closed during the 2023 period.

Interest Expense. Interest expense for Holdings, which includes amortization of debt issuance costs and original issue discount and amortization of accumulated gains for swap amendments, was $72.3 million during the 2024 period compared with $73.9 million during the 2023 period. The interest expense attributable to CUSA, which includes amortization of debt issuance costs and original issue discount and amortization of accumulated losses for swap amendments, was $60.2 million during the 2024 period compared with $61.8

million during the 2023 period. The decrease in interest expense was primarily due to the redemption of our 8.75% Secured Notes, partially offset by a higher average interest rate on our term loan borrowings. See further discussion at Liquidity and Capital Resources below.

Interest Income. Interest income for Holdings was $26.1 million during the 2024 period compared with $24.9 million during the 2023 period. The interest income attributable to CUSA was $19.7 million during the 2024 period compared with $19.3 million during the 2023 period. The increase in interest income reflects higher average cash and cash equivalents balances and higher interest rates earned on those balances.

Loss on Debt Amendments and Extinguishments. We recorded a loss on amendment and extinguishment of debt of $2.5 million during the 2024 period related to the amendment of our term loan and the redemption of the remaining 8.75% Secured Notes, including the write-off of unamortized debt issuance costs and original issue discount, and legal and other fees paid. We recorded a loss on amendment and extinguishment of debt of $10.7 million during the 2023 period related to the amendment of our Senior Secured Credit Facilities and the partial redemption of the 8.75% Secured Notes, including the write-off of unamortized debt issuance costs and legal and other fees paid. See Note 7 to the condensed consolidated financial statements for information about our loss on debt amendments and extinguishments.

Foreign currency exchange and other related loss. We recorded a foreign currency exchange loss of $4.9 million during the 2024 period compared with a loss of $8.4 million during the 2023 period. Activity for the 2023 period includes a $4.9 million loss associated with Blue Chip Swap transactions. Excluding the impact of the Blue Chip Swap transactions, the loss on foreign exchange is primarily related to currency exchange fluctuations from original transactions dates until settlement. See note 14 to the condensed consolidated financial statements for a discussion of Blue Chip Swap transactions.

Equity in Income (Loss) of Affiliates. Equity in income of affiliates of $6.3 million was recorded during the 2024 period compared with equity in loss of affiliates of $0.3 million during the 2023 period driven by higher income earned from our investment in ACJV, LLC during the 2024 period and the absence of a loss from our investment in NCMI, which is now accounted for under the fair value basis of accounting. See Note 8 and Note 9, respectively, to the condensed consolidated financial statements for information about our investment in NCMI and our equity investments.

Net Gain on Investment in NCMI. We recorded a net gain on our investment in NCMI of $1.2 million during the 2024 period compared with $9.2 million during the 2023 period, primarily related to the mark-to-market adjustment of our investment in NCMI under the fair value basis of accounting. See Note 8 to the condensed consolidated financial statements for information about our investment in NCMI.

Income Taxes - Holdings. An income tax benefit of $28.6 million was recorded for the 2024 period compared with income tax expense of $8.4 million for the 2023 period. The effective tax rate was approximately (66.0)% for the 2024 period compared with 6.7% for the 2023 period. During the 2024 period, a deferred tax benefit of $39.5 million was recorded discretely related to the release of valuation allowances in certain foreign jurisdictions. The release of these valuation allowances was the result of the availability of positive evidence related to sustained taxable income in the relevant jurisdictions to support the future realizability of deferred tax assets. This discrete benefit favorably impacted the effective tax rate for the 2024 period, causing the income tax benefit to vary significantly from the tax expense derived by applying the statutory tax rate to the pre-tax income for the period. The effective tax rate for the 2023 period was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in certain foreign jurisdictions. Income tax provisions for interim periods are generally based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Income Taxes - CUSA. An income tax benefit of $27.9 million was recorded for the 2024 period compared with income tax expense of $6.8 million for the 2023 period. The effective tax rate was approximately (55.0)% for the 2024 period compared with 5.0% for the 2023 period. During the 2024 period, a deferred tax benefit of $39.5 million was recorded discretely related to the release of valuation allowances in certain foreign jurisdictions. The release of these valuation allowances was the result of the availability of positive evidence related to sustained taxable income in the relevant jurisdictions to support the future realizability of deferred tax assets. This discrete benefit favorably impacted the effective tax rate for the 2024 period, causing the income tax benefit to vary significantly from the tax expense derived by applying the statutory tax rate to the pre-tax income for the period. The effective tax rate for the 2023 period was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in certain foreign jurisdictions. Income tax provisions for interim periods are generally based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Income Taxes - Valuation Allowances

The Company assesses the likelihood that it will be able to recover its deferred tax assets against future sources of taxable income and reduces the carrying amounts of deferred tax assets by recording a valuation allowance, if, based on all available evidence, the Company believes it is more likely than not that all or a portion of such assets will not be realized. There is a possibility that within the next 12 months, sufficient positive evidence may become available to reach a conclusion that a portion of the valuation allowance in the U.S. will no longer be required.

Liquidity and Capital Resources

Operating Activities

We primarily collect our revenue in cash, mainly through box office receipts and the sale of concessions. Our revenue is generally received in cash prior to the payment of related expenses; therefore, we have an operating “float” and historically have not required traditional working capital financing. However, our working capital position will continue to fluctuate based on seasonality, the timing and volume of new film content, the timing of interest payments on our long-term debt as well as timing of payment of other operating expenses that are paid annually or semi-annually, such as property and other taxes and incentive bonuses. We believe our existing cash and expected cash flows from operations will be sufficient to meet our working capital, capital expenditures, and expected cash requirements from known contractual obligations for the next twelve months and beyond.

Cash provided by operating activities was $162.2 million for Holdings and $164.9 million for CUSA for the six months ended June 30, 2024, compared with cash provided by operating activities of $251.1 million for Holdings and $256.0 million for CUSA for the six months ended June 30, 2023. The decrease in cash provided by operating activities was primarily driven by the timing and level of revenue earned during each period partially offset by the timing of payments to vendors for expenses incurred during each period.

Investing Activities

Investing activities have been principally related to the development and remodel of theatres. New theatre openings and remodels historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $46.4 million and $54.6 million for the six months ended June 30, 2024 and 2023, respectively. The decrease in cash used for investing activities was primarily due to the level of capital expenditures during each period.

Below is a summary of capital expenditures, disaggregated by new and existing theatres, for the six months ended June 30, 2024 and 2023 (in millions):


	Six Months Ended June 30,
	2024		2023
New theatres	$	2.8	$	2.5
Existing theatres		44.4		52.1
Total capital expenditures	$	47.2	$	54.6

We operated 502 theatres with 5,708 screens worldwide as of June 30, 2024. Theatres and screens opened and closed during the six months ended June 30, 2024 were as follows:


	January 1, 2024		Built		Closed			June 30, 2024
U.S. (42 states)
Theatres		309		—		(1	)		308
Screens		4,324		—		(21	)		4,303

International (13 countries)
Theatres		192		2		—			194
Screens		1,395		10		—			1,405

Worldwide
Theatres		501		2		(1	)		502
Screens		5,719		10		(21	)		5,708

As of June 30, 2024, the following signed commitments were outstanding:


	Theatres (1)		Screens (1)		Estimated Remaining Investment (2)
Remainder of 2024
U.S.		1		7	$	12.9
International		—		—		—
Total		1		7	$	12.9

Subsequent to 2024
U.S.		2		26	$	17.0
International		—		—		—
Total	2		26		$	17.0

Total commitments at June 30, 2024	3		33		$	29.9

(1)

Based on the expected theatre opening date.

(2)

Approximately $12.9 million is expected to be paid during the remainder of 2024 and $4.3 million, $7.9 million and $4.8 million is expected to be paid during 2025, 2026 and 2027, respectively. The timing of payments is subject to change in the event of construction or other delays.

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. During the next twelve months and the foreseeable future, we plan to fund capital expenditures for our continued development with cash flow from operations and, if needed, borrowings under our senior secured credit facility, proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Financing Activities

Cash used for financing activities was $168.1 million and $110.8 million for the six months ended June 30, 2024 and 2023, respectively. The increase in cash used for financing activities was primarily due to the redemption of the remaining 8.75% secured notes during the six months ended June 30, 2024.

Holdings, at the discretion of its board of directors and subject to applicable law, may pay dividends on its common stock. The amount of the dividends to be paid in the future, if any, will depend upon available cash balances, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, and future prospects for earnings and cash flows, as well as other relevant factors. As a result of the impact of the COVID-19 pandemic, Holdings’ Board of Directors has suspended the quarterly dividend to shareholders.

We may, from time to time, seek to retire or repurchase our outstanding debt securities through cash purchases or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on the availability and prices of such debt securities, prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

See Note 7 for a summary of long-term debt outstanding as of June 30, 2024 for Holdings and CUSA.

Contractual Obligations

There have been no material changes in the contractual obligations previously disclosed in “Liquidity and Capital Resources” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed February 16, 2024.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

4.50% Convertible Senior Notes

On August 21, 2020, Holdings issued $460.0 million 4.50% convertible senior notes (the “4.50% Convertible Senior Notes”). The notes will mature on August 15, 2025, unless earlier repurchased or converted. Interest on the notes is payable on February 15 and August 15 of each year.

Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last

reported sale price of Holdings’ common stock and the conversion rate on each such trading day; (2) if Holdings distributes to all or substantially all stockholders (i) rights, options or warrants entitling them to purchase shares at a discount to the recent average trading price of Holdings’ common stock (including due to a stockholder rights plan) or (ii) Holdings’ assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of Holdings’ common stock; or (3) upon the occurrence of specified corporate events as described further in the indenture. Beginning May 15, 2025, holders may convert their notes at any time prior to the close of business on the third scheduled trading day immediately preceding the maturity date, or during any calendar quarter (and only during such calendar quarter), if the last reported sale price of Holdings’ common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to $18.66 per share (130% of the initial conversion price of $14.35 per share), on each applicable trading day. Upon conversion of the 4.50% Convertible Senior Notes, Holdings will pay or deliver cash, shares of its common stock or a combination of cash and shares of its common stock, at its election.

The current conversion rate is 69.6767 shares of Holdings’ common stock per one thousand dollars principal amount of the 4.50% Convertible Senior Notes. The conversion rate will be subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture occurs prior to the maturity date, Holdings will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with such make-whole fundamental change.

The 4.50% Convertible Notes are effectively subordinated to any of Holdings’, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.50% Convertible Notes are structurally subordinated to all existing and future debt and other liabilities, including trade payables, and including CUSA’s 5.25% Senior Notes due 2028 and 5.875% Senior Notes due 2026, or, collectively, CUSA’s senior notes (but excluding all obligations under the Credit Agreement, as defined below, which are guaranteed by Holdings). The 4.50% Convertible Notes rank equally in right of payment with all existing and future unsubordinated debt, including all obligations under the Credit Agreement, which is guaranteed by Holdings, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.50% Convertible Notes. The 4.50% Convertible Notes are not guaranteed by any of Holdings' subsidiaries.

Senior Secured Credit Facility

On May 26, 2023, CUSA amended and restated its senior secured credit facility (the “Credit Agreement”) to provide for an aggregate principal amount of $775.0 million, consisting of a $650.0 million term loan with a maturity date of May 24, 2030 and a $125.0 million revolving credit facility with a maturity date of May 26, 2028. The term loan is subject to a springing maturity date of April 15, 2028 if CUSA’s 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such date. The revolving credit facility is subject to springing maturity dates of December 14, 2025 and April 15, 2028 if CUSA’s 5.875% Senior Notes due 2026 and 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such dates, as more specifically described in the Credit Agreement.

On May 28, 2024, CUSA amended and restated its senior secured credit facility to reduce the rate at which the term loan bears interest by 0.50% and reset the 101% soft call for another six months (the “2024 Amendment”). See below for additional discussion of interest rates on the term loan, and Note 7 to the condensed consolidated financial statements for additional information on the 2024 Amendment.

Under the Credit Agreement, principal payments of $1.6 million are due on the term loan quarterly through March 31, 2030, with a final principal payment of the remaining unpaid principal due on May 24, 2030.

Pursuant to the 2024 Amendment noted above, interest on the term loan accrues, at CUSA's option, at either (i) a rate determined by reference to the secured overnight financing rate ("SOFR") as published by CME Group Benchmark Administration Limited and identified by Barclay's Bank PLC (the Administrative Agent) as the forward-looking term rate based on SOFR for a period of 1, 3, or 6 months (depending upon the Interest Period (as defined in the Credit Agreement) chosen by CUSA) (the “Term SOFR Rate”), subject to a floor of 0.50% per annum, plus an applicable margin of 3.25% per annum, or (ii) for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day, plus 1/2 of 1.00% and (c) the Term SOFR Rate for a one month Interest Period, as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1.00% (this clause (ii), the "Alternate Base Rate"), subject in the case of this clause (ii) to a floor of 1.50% per annum, plus, in the case of this clause (ii), an applicable margin of 2.25% per annum effective.

Interest on revolving credit loans accrues, at CUSA's option, at either (i) the Term SOFR Rate plus an applicable margin that ranges from 3.00% to 3.50% per annum, or (ii) the Alternate Base Rate, subject, in the case of this clause (ii) to a floor of 1.00% per annum, plus, in the case of this clause (ii), an applicable margin that ranges from 2.00% to 2.50%. The applicable margin with respect to revolving credit loans is a function of the Consolidated Net Senior Secured Leverage Ratio as defined in the Credit Agreement. As of June 30, 2024, the applicable margin was 3.25%, however, there were no borrowings outstanding under the revolving line of credit. In addition, CUSA is required to pay a commitment fee on the revolving line of credit that accrues at a rate ranging from 0.20% to

0.375% per annum of the daily unused portion of the revolving line of credit. The commitment fee rate is a function of the Consolidated Net Senior Secured Leverage Ratio and was 0.25% at June 30, 2024.

CUSA’s obligations under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of Holdings other than CUSA (the “Other Guarantors”) and are secured by security interests in substantially all of CUSA’s, Holdings’ and the Other Guarantors’ personal property.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on the ability of Holdings, CUSA and their subsidiaries to: merge, consolidate, liquidate, or dissolve; sell, transfer or otherwise dispose of assets; create, incur or permit to exist certain indebtedness and liens; pay dividends, repurchase stock and make other Restricted Payments (as defined in the Credit Agreement); prepay certain indebtedness; make investments; enter into transactions with affiliates; and change the nature of their business. At any time that CUSA has revolving credit loans outstanding, it is not permitted to allow the Consolidated Net Senior Secured Leverage Ratio to exceed 3.5 to 1.0. As of June 30, 2024, there were no revolving credit loans outstanding, and CUSA’s Consolidated Net Senior Secured Leverage Ratio was 0.2 to 1.

The Credit Agreement also includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, a change of control, material money judgments and failure to maintain security interests. If an event of default occurs, all commitments under the Credit Agreement may be terminated and all obligations under the Credit Agreement could be accelerated by the Lenders, causing all loans outstanding (including accrued interest and fees payable thereunder) to be declared immediately due and payable.

The Restricted Payments covenant, as defined in the Credit Agreement generally does not limit the ability of Holdings and its subsidiaries to pay dividends and make other Restricted Payments if the Consolidated Net Total Leverage Ratio (as defined in the Credit Agreement) is less than or equal to 2.75 to 1.00. If the Consolidated Net Total Leverage Ratio is greater than 2.75 to 1.00, but not greater than 5.00 to 1.00, Restricted Payments generally may be made in an aggregate amount not to exceed the Available Amount (as defined in the Credit Agreement), which is a function of CUSA’s Consolidated EBITDA minus 1.75 times its Consolidated Interest Expense (as such terms are defined in the Credit Agreement) and certain other factors as specified in the Credit Agreement. As of June 30, 2024, the Consolidated Net Total Leverage Ratio was 2.34 to 1.00 and the Available Amount was $654.0 million. In addition, the Credit Agreement contains other baskets that allow certain Restricted Payments in excess of the Applicable Amount.

We have three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the term loan outstanding. See Note 7 to the condensed consolidated financial statements for discussion of the interest rate swaps.

As of June 30, 2024, there was $641.9 million outstanding under the term loan and no borrowings were outstanding under the $125.0 million revolving line of credit. The average interest rate on outstanding term loan borrowings under the Credit Agreement as of June 30, 2024 was approximately 7.1% per annum, after giving effect to the interest rate swap agreements.

5.875% Senior Notes

On March 16, 2021, CUSA issued $405.0 million aggregate principal amount of 5.875% senior notes due 2026, at par value (the “5.875% Senior Notes”). Interest on the 5.875% Senior Notes is payable on March 15 and September 15 of each year. The 5.875% Senior Notes mature on March 15, 2026.

The 5.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA's subsidiaries that guarantee, assume or become liable with respect to any of CUSA's or a guarantor’s debt. The 5.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of CUSA's and its guarantor’s existing and future senior debt and senior in right of payment to all of CUSA’s and its guarantors’ existing and future senior subordinated debt. The 5.875% Senior Notes and the guarantees are effectively subordinated to all of CUSA’s and its guarantor’s existing and future secured debt to the extent of the value of the collateral securing such debt, including all borrowings under CUSA’s Credit Agreement. The 5.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of CUSA's subsidiaries that do not guarantee the 5.875% Senior Notes. CUSA may redeem the 5.875% Senior Notes in whole or in part at redemption prices specified in the indenture. See Note 20 to the condensed consolidated financial statements and Recent Developments above for a discussion of the tender offer for the 5.875% Senior Notes completed on July 18, 2024.

5.25% Senior Notes

On June 15, 2021, CUSA issued $765.0 million aggregate principal amount of 5.25% senior notes due 2028, at par value (the “5.25% Senior Notes”). Interest on the 5.25% Senior Notes is payable on January 15 and July 15 of each year. The 5.25% Senior Notes mature on July 15, 2028.

The 5.25% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA's or a guarantor’s debt. The 5.25% Senior Notes and the guarantees will be CUSA’s and the guarantors’ senior unsecured obligations and (i) rank equally in right of payment to

CUSA’s and the guarantors’ existing and future senior debt, including borrowings under CUSA's Credit Agreement (as defined below) and CUSA’s existing senior notes, (ii) rank senior in right of payment to CUSA’s and the guarantors’ future subordinated debt, (iii) are effectively subordinated to all of CUSA’s and the guarantors’ existing and future secured debt, including all obligations under the Credit Agreement, to the extent of the value of the collateral securing such debt, (iv) are structurally subordinated to all existing and future debt and other liabilities of CUSA’s non-guarantor subsidiaries, and (v) are structurally senior to the 4.50% convertible senior notes due 2025 issued by Holdings.

Prior to July 15, 2024, CUSA may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. On or after July 15, 2024, CUSA may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to July 15, 2024, CUSA may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption.

8.75% Secured Notes

On April 20, 2020, CUSA issued $250.0 million 8.75% senior secured notes (the “8.75% Secured Notes”) with a maturity date of May 1, 2025. Interest on the 8.75% Secured Notes was payable on May 1 and November 1 of each year. CUSA could redeem the 8.75% Secured Notes in whole or in part at redemption prices specified in the indenture.

On May 1, 2023, CUSA redeemed $100.0 million in principal amount of the 8.75% Secured Notes plus accrued interest thereon for $106.6 million in cash. Following the redemption, $150.0 million in aggregate principal amount of the 8.75% Secured Notes remained outstanding.

On May 1, 2024, CUSA redeemed the remaining $150.0 million in outstanding principal amount of the 8.75% Secured Notes at par plus accrued interest thereon for $156.6 million in cash. Upon redemption, the indenture governing the 8.75% Secured Notes was fully satisfied and discharged. See Note 7 to the condensed consolidated financial statements for additional information on the redemption.

Borrowing of International Subsidiaries

As of June 30, 2024, one of the Company’s international subsidiaries had a bank loan outstanding of $5.5 million that matures in January 2029. The interest rate on the bank loan outstanding at June 30, 2024 was 4.0%.

Covenant Compliance

The indentures governing the 5.875% Senior Notes and the 5.25% Senior Notes ("the indentures") contain covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of June 30, 2024, CUSA could have distributed up to approximately $3.7 billion to its parent company and sole stockholder, Holdings, under the terms of the indentures, subject to its available cash and other borrowing restrictions outlined in the indentures. Upon a change of control, as defined in the indentures, CUSA would be required to make an offer to repurchase the 5.875% Senior Notes and the 5.25% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indentures allow CUSA to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of June 30, 2024 was 5.7 to 1.

See discussion of dividend restrictions and the net senior secured leverage ratio under the Credit Agreement at Senior Secured Credit Facility above.

As of June 30, 2024, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in interest rates and foreign currency exchange rates.

Interest Rate Risk

The Company currently has variable rate debt. An increase or decrease in interest rates would affect its interest expense related to this variable rate debt. At June 30, 2024, we had an aggregate of $197.4 million of variable rate debt outstanding, after giving effect to the interest rate swaps. Based on the interest rates in effect on the variable rate debt outstanding at June 30, 2024, a 100 basis point increase in market interest rates would increase our annual interest expense by $2.0 million.

The tables below provide information about Holdings' and CUSA’s fixed rate and variable rate long-term debt agreements as of June 30, 2024. The Company has three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt. See Interest Rate Swap Agreements below. Holdings’ long-term debt agreements include fixed rate and variable rate long-term debt of CUSA, which is guaranteed by Holdings.

Holdings Debt


	Expected Maturity for the Twelve Months Ending June 30,																Average
	(in millions)																Interest
	2025		2026 (2)		2027		2028		2029		Thereafter		Total		Fair Value		Rate
Fixed rate	$	—	$	865.0	$	—	$	—	$	765.0	$	450.0	$	2,080.0	$	2,318.3		5.5	%
Variable rate		7.6		7.5		7.5		7.5		7.6		159.7		197.4		199.1		8.5	%
Total debt (1)	$	7.6	$	872.5	$	7.5	$	7.5	$	772.6	$	609.7	$	2,277.4	$	2,517.4		5.7	%

(1)

Amounts are presented before adjusting for debt issuance costs.

(2)

On July 18, 2024, concurrently with the issuance of $500 million 7.0% Senior Notes due 2032, CUSA completed a tender offer to purchase any and all of its 5.875% Senior Notes, of which $345.3 million was tendered at the expiration of the tender offer. See Note 20 to the condensed consolidated financial statements.

CUSA Debt


	Expected Maturity for the Twelve Months Ending June 30,																Average
	(in millions)																Interest
	2025		2026 (2)		2027		2028		2029		Thereafter		Total		Fair Value		Rate
Fixed rate	$	—	$	405.0	$	—	$	—	$	765.0	$	450.0	$	1,620.0	$	1,589.5		5.7	%
Variable rate		7.6		7.5		7.5		7.5		7.6		159.7		197.4		199.1		8.5	%
Total debt (1)	$	7.6	$	412.5	$	7.5	$	7.5	$	772.6	$	609.7	$	1,817.4	$	1,788.6		6.0	%

(1)

Amounts are presented before adjusting for debt issuance costs.

(2)

Interest Rate Swap Agreements

All of the interest rate swap agreements qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on each of Holdings’ and CUSA’s condensed consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. See Note 7 to the condensed consolidated financial statements for further discussion of the interest rate swap agreements.

Foreign Currency Exchange Rate Risk

There have been no material changes in foreign currency exchange rate risk previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed February 16, 2024.

Item 4. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of June 30, 2024, under the supervision and with the participation of Holdings’ and CUSA’s principal executive officer and principal financial officer, Holdings and CUSA carried out an evaluation required by the Exchange Act of the effectiveness of the design and operation of their respective disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, Holdings’ and CUSA’s principal executive officer and principal financial officer concluded that, as of June 30, 2024, each of Holdings’ and CUSA’s respective disclosure controls and procedures were effective to provide reasonable assurance that information

required to be disclosed by each of Holdings and CUSA in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to Holdings’ and CUSA’s management, including Holdings’ and CUSA’s principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

There have been no changes in Holdings’ and CUSA’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended June 30, 2024 that materially affected, or are reasonably likely to materially affect, Holdings’ and CUSA’s internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Other than the discussion at Note 18, there have been no material changes from legal proceedings previously reported under “Business – Legal Proceedings” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed February 16, 2024.

Item 1A. Risk Factors

We believe there have been no material changes in our risk factors from those disclosed in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed February 16, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds


	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased As Part of Publicly Announced Plans		Approximate Dollar Value of Shares that May Yet Be Purchased Under Publicly Announced Plan
April 1 through April 30		1.35	$	18.30		—		—
May 1 through May 31		10.31	$	17.37		—		—
June 1 through June 30		0.17	$	16.80		—		—
Total		11.83				—		—

(1) Represents shares of Holdings’ common stock (in thousands) repurchased in April, May and June of 2024 to satisfy employee tax-withholding obligations upon vesting in restricted stock and performance stock units. See Note 10 to the condensed consolidated financial statements.

For a description of limitations on the payment of Holdings’ dividends, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.”

Item 5. Other Information

Supplemental Schedules Specified by the Senior Notes Indentures

As required by the indentures governing CUSA’s 5.875% Senior Notes and 5.25% Senior Notes, collectively “the senior notes”, CUSA has included in this filing interim financial information for its subsidiaries that have been designated as unrestricted subsidiaries, as defined by the indentures. As required by these indentures, CUSA has included an unaudited condensed consolidating balance sheet and unaudited condensed consolidating statements of income, comprehensive income and cash flows for CUSA. See Liquidity and Capital Resources at Part I - Item 2 for discussion of the senior notes, including relevant covenants and restrictions. The following supplementary schedules separately identify CUSA’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures.


		Page
Unaudited Condensed Consolidating Balance Sheet as of June 30, 2024		56

Unaudited Condensed Consolidating Statement of Income for the six months ended June 30, 2024		57

Unaudited Condensed Consolidating Statement of Comprehensive Income for the six months ended June 30, 2024		58

Unaudited Condensed Consolidating Statement of Cash Flows for the six months ended June 30, 2024		59

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF JUNE 30, 2024

(in millions, unaudited)


	Restricted		Unrestricted
	Group		Group			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	432.8	$	122.0		$	—		$	554.8
Other current assets		412.0		(116.6	)		(12.2	)		283.2
Total current assets		844.8		5.4			(12.2	)		838.0
Theatre properties and equipment, net		1,125.8		—			—			1,125.8
Operating lease right-of-use assets, net		990.2		—			—			990.2
Other long-term assets		1,747.5		289.5			(375.2	)		1,661.8
Total assets	$	4,708.3	$	294.9		$	(387.4	)	$	4,615.8
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7.6	$	—		$	—		$	7.6
Current portion of operating lease obligations		210.5		—			—			210.5
Current portion of finance lease obligations		15.9		—			—			15.9
Current income tax payable		2.3		—			—			2.3
Accounts payable and accrued expenses		548.2		—			(12.2	)		536.0
Total current liabilities		784.5		—			(12.2	)		772.3
Long-term liabilities
Long-term debt, less current portion		2,048.9		—			(262.2	)		1,786.7
Operating lease obligations, less current portion		850.9		—			—			850.9
Finance lease obligations, less current portion		92.2		—			—			92.2
Other long-term liabilities and deferrals		446.0		0.6			—			446.6
Total long-term liabilities		3,438.0		0.6			(262.2	)		3,176.4
Commitments and contingencies
Equity		485.8		294.3			(113.0	)		667.1
Total liabilities and equity	$	4,708.3	$	294.9		$	(387.4	)	$	4,615.8

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF INCOME

SIX MONTHS ENDED JUNE 30, 2024

(in millions, unaudited)


	Restricted			Unrestricted
	Group			Group		Eliminations			Consolidated
Revenue	$	1,313.4		$	—	$	—		$	1,313.4
Cost of operations
Theatre operating costs		1,007.0			—		—			1,007.0
General and administrative expenses		102.7			—		—			102.7
Depreciation and amortization		99.2			—		—			99.2
Loss on disposal of assets and other		2.1			—		—			2.1
Total cost of operations		1,211.0			—		—			1,211.0
Operating income		102.4			—		—			102.4
Interest expense		(61.6	)		—		1.4			(60.2	)
Equity in income of affiliates		0.7			5.6		—			6.3
Interest expense - NCM		(11.1	)		—		—			(11.1	)
Other income		9.2			5.7		(1.4	)		13.5
Total other expense		(62.8	)		11.3		—			(51.5	)
Income before income taxes		39.6			11.3		—			50.9
Income tax (benefit) expense		(30.2	)		2.3		—			(27.9	)
Net income		69.8			9.0		—			78.8
Less: Net income attributable to noncontrolling interests		1.3			—		—			1.3
Net income attributable to Cinemark USA, Inc.	$	68.5		$	9.0	$	—		$	77.5

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

SIX MONTHS ENDED JUNE 30, 2024

(in millions, unaudited)


	Restricted			Unrestricted
	Group			Group		Eliminations		Consolidated
Net income	$	69.8		$	9.0	$	—	$	78.8
Other comprehensive loss, net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements		3.8			—		—		3.8
Foreign currency translation adjustments		(22.9	)		—		—		(22.9	)
Total other comprehensive loss, net of tax		(19.1	)		—		—		(19.1	)
Total comprehensive income, net of tax		50.7			9.0		—		59.7
Comprehensive income attributable to noncontrolling interests		(1.3	)		—		—		(1.3	)
Comprehensive income attributable to Cinemark USA, Inc.	$	49.4		$	9.0	$	—	$	58.4

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

SIX MONTHS ENDED JUNE 30, 2024

(in millions, unaudited)


	Restricted			Unrestricted
	Group			Group			Eliminations		Consolidated
Operating activities
Net income	$	69.8		$	9.0		$	—	$	78.8
Adjustments to reconcile net income to cash used for operating activities		55.6			(2.8	)		—		52.8
Changes in assets and liabilities		34.2			(0.9	)		—		33.3
Net cash provided by operating activities		159.6			5.3			—		164.9
Investing activities
Additions to theatre properties and equipment		(47.2	)		—			—		(47.2	)
Proceeds from sale of assets and other		0.2			—			—		0.2
Proceeds from redemption of common units of NCM		—			0.6			—		0.6
Net cash used for investing activities		(47.0	)		0.6			—		(46.4	)
Financing activities
Redemption of 8.75% Notes		(150.0	)		—			—		(150.0	)
Payment of debt issuance costs		(0.8	)		—			—		(0.8	)
Payment of fees on amendments of senior secured credit facility		(0.3	)		—			—		(0.3	)
Repayments of long-term debt		(3.9	)		—			—		(3.9	)
Restricted stock withholdings for payroll taxes		(4.4	)		—			—		(4.4	)
Payments on finance leases		(7.5	)		—			—		(7.5	)
Other financing activities		(1.2	)		—			—		(1.2	)
Net cash used for financing activities		(168.1	)		—			—		(168.1	)
Effect of exchange rate changes on cash and cash equivalents		(8.0	)		—			—		(8.0	)
(Decrease) Increase in cash and cash equivalents		(63.5	)		5.9			—		(57.6	)
Cash and cash equivalents:
Beginning of year		496.3			116.1			—		612.4
End of year	$	432.8		$	122.0		$	—	$	554.8

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

Item 6. Exhibits


10.1		Cinemark Holdings, Inc. 2024 Long-Term Incentive Plan dated May 15, 2024 (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed May 20, 2024)..
10.2		First Amendment dated as of May 28, 2024, to the Second Amended and Restated Credit Agreement, dated as of May 26, 2023 among Cinemark Holdings, Inc., Cinemark USA, Inc. the lenders from time to time parties thereto, the other agents and arrangers named therein and Barclay’s Bank PLC, as administrative agent (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s and Cinemark USA, Inc’s Current Report on Form 8-K, File No. 001-33401, filed May 30, 2024).
*10.3		Fifth Amendment, dated as of April 26, 2024, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord, and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA.
*10.4		Ninth Amendment, dated as of June 5, 2024, to Indenture of Lease, dated as of September 30, 1995, by an between Syufy Enterprises, L.P. as landlord, and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV.
*10.5		Tenth Amendment, dated as of June 13, 2024, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord, and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA.
*31.1		Certification of Sean Gamble, Chief Executive Officer of Cinemark Holdings, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.2		Certification of Melissa Thomas, Chief Financial Officer of Cinemark Holdings, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.3		Certification of Sean Gamble, Chief Executive Officer of Cinemark USA, Inc., pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
*31.4		Certification of Melissa Thomas, Chief Financial Officer of Cinemark USA, Inc., pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
**32.1		Certification of Sean Gamble, Chief Executive Officer of Cinemark Holdings, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
**32.2		Certification of Melissa Thomas, Chief Financial Officer of Cinemark Holdings, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
**32.3		Certification of Sean Gamble, Chief Executive Officer of Cinemark USA, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes – Oxley Act of 2002.
**32.4		Certification of Melissa Thomas, Chief Financial Officer of Cinemark, USA, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes – Oxley Act of 2002.
**101		The following material from the combined Cinemark Holdings, Inc. and Cinemark USA, Inc. Form 10-Q for the quarter ended June 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language), filed herewith: (i) Cinemark Holdings, Inc. Condensed Consolidated Balance Sheets (ii) Cinemark Holdings, Inc. Condensed Consolidated Statements of Income (iii) Cinemark Holdings, Inc. Condensed Consolidated Statements of Comprehensive Income (iv) Cinemark Holdings, Inc. Condensed Consolidated Statements of Equity (v) Cinemark Holdings, Inc. Condensed Consolidated Statements of Cash Flows (vi) Cinemark USA, Inc. Condensed Consolidated Balance Sheets (vii) Cinemark USA, Inc. Condensed Consolidated Statements of Income (viii) Cinemark USA, Inc. Condensed Consolidated Statements of Comprehensive Income (ix) Cinemark USA, Inc. Condensed Consolidated Statements of Equity (x) Cinemark USA, Inc. Condensed Consolidated Statements of Cash Flows (xi) Notes to Condensed Consolidated Financial Statements of Cinemark Holdings, Inc. and Cinemark USA, Inc.
* 104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* filed herewith.

** furnished herewith.

CINEMARK HOLDINGS, INC. AND

CINEMARK USA, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		CINEMARK HOLDINGS, INC. CINEMARK USA, INC.
		Registrants

DATE:	August 2, 2024

		/s/ Sean Gamble
		Sean Gamble
		Chief Executive Officer

		/s/ Melissa Thomas
		Melissa Thomas
		Chief Financial Officer